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Abstract.
A review of lanthanides and their luminescent properties, concentrating in particular on 
sensitized emission and the use of lanthanide chelates as reporter groups in assays, will be 
presented.
Assays of the format where a target (analyte) uniquely and selectively complexes with a 
labelled probe (reagent) is discussed. The labelling of probes with efficient luminescent 
reporter groups or radioisotopes is also highlighted, this allows for the accurate 
determination o f the concentration of target - probe conjugate. These types o f assay 
systems can be categorized into two classes, homogeneous and heterogeneous assays. The 
specific application of both formats in nucleic acid assays are discussed. Most assay 
systems are of the heterogeneous type which tend to be complicated and error prone, thus 
the need for homogeneous methods will be stressed. The development o f these systems, 
their current application to DNA assays and, more specifically, in the detection of 
nucleotide base sequences using lanthanide chelates as reporter groups is reviewed.
The synthesis of two novel intercalator probes, their derivatives based on the known 
sensitizer ligand PDCA (l,10-phenanthroline-2,9-dicarboxylic acid) and their luminescent 
complexes are presented.
A novel homogeneous assay for the detection of the point mutation which occurs in the 
DNA of Cystic Fibrosis sufferers is also presented. The assay utilizes two reagents to 
detect a specific DNA sequence in a longer nucleic strand, One, an oligonucleotide with 
a non-luminescent europium/EDTA chelate and the other, a duplex DNA intercalator 
linked via a short chain to a ligand capable of efficiently sensitizing europium 
luminescence upon complexation. A strongly luminescent temaiy complex is formed when 
a matched single stranded DNA target is mixed with probe and sensitizer reagents.
Assay results and trials will also be presented.
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The Lanthanides and their Complexes.
Review: The Lanthanides and their Complexes.
1.1 Introduction
1.1.1 The spectroscopic properties of the Lanthanides and their complexes.
The lanthanide elements, more specifically the trivalent Liri^ ions exhibit unique 
photophysical properties. M ost metal ion complexes absorb radiation, but very few re- 
emit the absorbed energy in the form of UV or visible photons. This is a result of efficient, 
facile, non-radiative deexcitation pathways. Luminescent transition metal complexes are 
rare, a result of the strong coupling o f their d-electron excited states with water 
molecules, via the ligand field, which provides an efficient deexcitation mechanism.
Lanthanide ions and their complexes are known to luminesce, especially in the anliydrous 
solid state, a property of the 4 f‘ electronic shells^^l
Lanthanides have the same electronic configuration in the outer shell ( 6 s^), the difference 
between them lies in the 4f electronic sub-shell. Lanthanide 4 f orbitals are heavily shielded 
from their chemical environment by the 5s^5p^ orbitals as shown in Table 1 . As a 
consequence of this shielding the 4 f orbitals are not involved in bonding. There is little 
disruption of the electronic transitions between energy levels in the f  orbitals, this has a 
direct bearing on the radiationless deactivating processes that can occur. With lanthanide 
metals, luminescent processes can compete efficiently, unlike transition metals.
The energy of the 4f" configuration o f the lanthanide ion is determined by a number of 
factors including electrostatic interactions, coordination environment and the spin orbit 
coupling, this is shown in F igure
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Element Ln®
Lantliamun La 5d'6s" 4P
Cerium Ce 4f'5d'6s^ 4P
Praesodymium Pr 4 f6 s ' 4P
Neodymium Nd 4 f6 s ' 4P
Promethium Pm 4P 6  S ' 4P
Samarium Sm 4f6s- 4P
Europium Eu 4f6s^ 4P
Gadolinium Gd 4P6s= 4P
Terbimn Tb 4f6s- 4P
Dysprosium Dy 4f‘“6s- 4P
Hohnium Ho 4f'6s" 4P"
Erbium Er 4 f'6 s ' 4 f i
Thulium Tm 4P"6s- 4P"
Ytterbium Yb 4 f ' 6 s ' 4P"
Lutetium Lu 4f"5d^6s- 4P"
The electronic configuration o f the Lanthanides.
E.I.
4f6
5D
7f
s.o.
5Dj=0-4
Kricm-l
S.O. lO^cnrl
L.F.
'7Fj=0-6
Figure 1 Splitting o f the europium 4 f  level.
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Using the Judd-Olfelt theory^^  ^ the intensities of the f-f absorption spectra can be 
explained. The Laporte rule forbids any transitions between the 4f levels that do not 
include any change in parity, but they can occur when interaction with the ligand field 
causes mixing of electronic states^‘^1 Transitions between modified states are called forced 
(or induced) electric dipole transitions. The possibility o f these occurring is small (<1)^^^  
and their lifetimes are long, around 10'® seconds.
The rate of radiationless decay is a function of the energy gap. Europium and terbium ions 
have large energy gaps and emit strongly in the visible spectrum. Europium ion emission 
consists of transitions from the levels, mainly the level, to the level, as shown 
in Figures 2 and 3.
The emissive levels o f europium ions (®Dq) and terbium ions (®DJ lie 17250cm'^ (580nm) 
and 20500cm‘^  (488nm) above the ground level. The allowed transitions in europium are 
2 ,4 ,6 - The strongest emissions are observed in the and ^Dq-^Fz transitions.
The intensities of these two emissions are very sensitive to the detailed nature o f the ligand 
environment, reflecting the hypersensitive character of the ^Dq-^F^ transition. The 
^Do-"^ Fq3  5 transitions are strictly forbidden, emissions being virtually unobservable. Decay 
of the emitting ®Dq state is governed by non-radiative transitions, the evidence being poor 
emission quantum yields and lower experimental decay times than predicted^^l The theory 
of non-radiative transitions has been discussed in several papers^ ®'®’’’*^ and is thought to be 
due to the interaction o f the electronic states in the lanthanide ion with the vibrational 
modes of its environment, as shown in Table 2 .
!cK
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Transition Spectral
Region,
nm
Relative
Intensities
Other characteristics
Terbmm
485-500 medimn-sfrong moderately sensitive to ligand 
euviromnent
540-555 strongest best probe tiansition
580-595 medium moderately sensitive to ligand 
environment
615-625 medium-weak some str ucturing under high resolution
645-655 weak moderately sensitive to ligand 
enviiomnent
Europium
578-580 weak non-degenerate tr ansition: appears as a 
sharp line
^Do-*T, 585-600 stiougest sharp and structured under high 
resolution
610-630 strongest intensity exhibits hypersensitivity to 
ligand envir onment
645-660 weak always very weak
680-705 weak intensity and structuring very sensitive 
to ligand enviromneut
Table 2 The major characteristics o f terbium and europium emission spectra in 
aqueous solution.
Europium is a "hai’d" acid in the Pearson classification scheme^^  ^and has a preference for 
hard bases^ ^®\ paiticularly water molecules and hydroxide ions. Water molecules are often 
coordinated, with other ligands, to europium. The coordination of hydroxide ions to 
europium has a pronounced effect, namely that the non-radiative deactivation of the 
emitting ®Dq level occurs via weak vibronic coupling with the vibrational hydroxide
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oscillators^^^l As a consequence, lanthanide luminescence is rarely observed in aqueous 
solutions. Wlien hydroxide ions are replaced by lower frequency deuteroxide ions then the 
vibronic deactivation pathways become less efficient and luminescence increases.
The number of coordinated water molecules is proportional to the rate of radiationless de­
excitation. Horrocks and SudnicW^-' '^^ have exploited the differences in the lifetimes of 
various complexes of terbium and europium, in both water and deuterium oxide, to 
determine the number o f coordinated water molecules in their solvent shells. Equation 
1  estimates the number o f water molecules (n), where and x^^o are the experimental 
excited state lifetimes (ms) and q is 1.05 and 4.2 for europium and terbium respectively.
E quation 1
1 1
n  =  q
T H 2 O  T D 2 O
This method has been applied to various aminocarboxylate complexes including EDTA, 
NT A and HEDTA, as well as encapsulating ligands such as polyaza macrocycles.
Horrocks' work is important in that it provides design criteria for the evaluation o f new 
ligand systems and their effectiveness in excluding water, and as a consequence non- 
radiative losses fr om the lanthanide coordination sphere. The nature of the coordination 
environment has a pronounced effect on the luminescent intensity and lifetimes of the 
resulting complexes. These factors are controlled by the careflü choice o f ligand.
1.1.2 The coordination properties of the lanthanides.
Lanthanides are hard acids in the Pearson classification scheme^^  ^and share a number of 
common coordinating properties. Lanthanide coordination occurs via ionic bonding and 
ions tend to prefer negatively charged donors and hard bases, the order of preference
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being 0>N>S.
W ater molecules and hydroxide ions are extremely powerflil coordinating ligands of 
lanthanide ions in aqueous solution, especially at basic pH's. Hydroxide precipitation is a 
common problem and can only be overcome by the use o f donor groups bearing 
negatively charged oxygen ions. Neutral oxygen and nitrogen atoms can only bind to 
lanthanides if present in multidentate ligands also containing negatively charged oxygen 
ions. It is for this reason that many complexes o f the lanthanides are unstable in aqueous 
solution.
The conformational properties, size and nature o f the donor groups determine the 
coordination number and geometry o f the resulting complexes in lanthanide chemistry. 
This is because there is no directionality in lanthanide-ligand interactions. The most 
common coordination numbers o f lanthanides are eight and nine^ ^^ '^ ®^  and the hydration 
numbers for europium and terbium, in aqueous solution, averages between eight and
1.1.3 Sensitized Emission.
Europium and terbium are poor light absorbers with small absorption coefficients in the 
visible and UV spectral regions^®l The strongest absorption band o f europium aqueous in 
the near UV and visible region occurs at 393nm with an extinction coefficient of 3M'^cm'\
Sensitized emission from lanthanide chelates of organic ligands was first observed by 
Weissman^^’l He noticed that the absorption o f UV light by a variety of salicaldehyde and 
P-diketonate ligands resulted in the characteristic europium f-f transition emission lines, 
to which the ligands were coordinated.
Recent researcU^®’^ ’^“°’^ ^^  has referred to sensitized emission as the "antenna effect". 
Sensitized emission from europium and terbium ions arises via an intermolecular energy
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transfer process. The transfer is extremely fast, 5x10® - 10  ^sec '\ occurring via intersystem 
crossing between the triplet states o f the chelating ligand and the lanthanide ion emissive 
levels.
Crosby^ ^^  ^published a mechanism for sensitized emission and is shown in F igure 4. In its 
simplest form, the model for the fluorescence o f a rare earth chelate can be simplified into 
four steps;
1) Excitation of the organic ligand from the ground singlet state Sq to the excited 
state Sj. The molecule rapidly loses its excess vibrational energy through non- 
radiative deactivation processes and falls to the lowest level o f S .^
2) Intersystem crossing within the excited ligand; energy is transferred from the 
singlet excited state to a triplet excited state of the ligand.
3) Intramolecular energy transfer; energy is transferred from the triplet excited state 
o f the ligand to the resonance levels o f the lanthanide ion (the levels responsible 
for luminescence in the lanthanide ion). This process does not occur in the 
luminescence o f organic molecules.
4) Radiative transitions resulting in light emission from the metal ion (metal ion 
luminescence).
First Excited Singlet State Triplet Donor
SI
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Acceptor
a
Absoi ption
Excitation
Fluorc iccncc
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Figure 4 The radiative processes in a chelate leading to europium ion 
luminescence.
For efficient lanthanide ion luminescence, non-radiative transitions must be minimised.
This requires;
1 ) Radiationless deactivating transitions of the excited lanthanide ion to be minimised.
2) Non-radiative transitions and radiative transitions S^-Sq and T^-Sq (ligand 
fluorescence and phosphorescence respectively) should be minimal. The excited 
triplet state of the ligand should have an appropriate lifetime, favouring energy 
transfer to the metal ion rather than phosphorescence or thermal decay pathways.
3) The resonance energy levels o f the lanthanide ion should be very close or just 
below that of the ligand triplet state, increasing the chance of transitions 
between the two levels.
10
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Kleinermann^^®^ proved the role o f the triplet level in lanthanide luminescence 
experimentally. He proposed that energy for the singlet (S J  level of the ligand could be 
transferred to the metal ion directly with rate constants o f > 1 0 "  sec '\ however this was 
not the case experimentally. Observed rate constants were in the order of 1 0 ® sec '\ This 
result could only be explained by triplet level participation.
1.1.4 Triplet sensitizers fp-diketonatesV
Occasionally chelates cannot be excited efficiently by a given wavelength. Triplet 
sensitizers, such as benzophenone or acetophenone, are often added to promote efficient 
excitation from the triplet level in the ligand. These sensitizers have a higher triplet energy 
level than that of the ligand and can be excited by the exact wavelength o f light required.
Matowich and Suzuld^ *^^  ^ and El-Sayed and BhaumiU"®  ^ observed intermolecular 
sensitization o f lanthanide/P-diketonate complexes by triplet sensitizers in the 1960's. 
Studies showed that energy transfer from the triplet state o f the sensitizer to the triplet 
level of the chelate occurred via collisional processes. This transfer, which occurs at a rate 
of > 1 0 ® sec '\ provides further confirmation o f the role o f the triplet level in the 
sensitization of lanthanide chelate luminescence. They also showed that the triplet level 
o f the ligand is higher than that o f the lanthanide ions' excited levels and that the triplet 
level of the sensitizer is liigher than that o f the chelate ligands. This provides the necessary 
conditions for efficient energy transfer.
Lanthanide luminescence is controlled by two major factors;
1) The ligand must be able to transfer energy from its triplet state to the resonance 
level o f the lanthanide ion.
2) The ease with which the excited state o f the lanthanide chelate is quenched.
11
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Sinha^ ^®^  showed that these factors are heavily influenced by the type of ligand, the 
lanthanide ion and the solvent used,
Filipescu -^^  ^attempted to correlate the effect of organic ligands on intermolecular transfer 
in terbium and europium chelates. Various p-diketonate complexes o f both lanthanides 
were studied in order to discover, if any, a relationship between the intensity o f 
luminescence and structure o f ligand or position o f triplet levels. No systematic trends 
were observed.
It is difficult to predict which organic ligands will form fluorescent complexes w ith the 
lanthanides. Semi-quantitative studies^ ^®^  on aromatic ligand complexes of lanthanides and 
their fluorescent properties have identified potential classes of ligands that can act as 
sensitizers o f europium and/or terbium ion luminescence. Amongst these ligands are 
phenanthroline, biphenyl, pyridine, quinoline and benzoic acid derivatives.
Mukhala^ ^^ '®°^  synthesised different 2 ,2 -bipyridine derivatives and other aromatic ligands, 
chelated with europium and terbium ions and their subsequent effect on the luminescent 
properties o f both. Some o f these are shown in Figure S.
The aim of the study was to enhance the relative luminescence yields in order to develop 
lanthanide chelates for use in immunoassays, t ie  proposed that substituents on the 
bipyridine molecule may have a significant effect on luminescent properties. The best 
relative luminescence yields (R) were obtained for molecules containing electron donating 
substituents (Me or Ph), whilst electron withdrawing substituents (NO2  or COOH) have 
the opposite effect. Tab le 3 shows no clear correlation between the relative luminescent 
yields and the substituent type could be found. Clearly it is important o f having a ligand 
triplet state at the right energy in relation to the energy levels of the lanthanide ion. The 
triplet state o f the ligand must lie above the resonance levels of the lanthanide ion for 
efficient energy transfer to take place.
12
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The triplet state of the acridine (22), isoquinoline (24), 3,3'- bis-isoquinoline (26) and 2,2'- 
bipyrimidine (28) ligands lies below the resonance level of the terbium ion and the result 
is the weak luminescence of the respective complexes. Also, despite the higher 
conjugation of benzyl(f)isoquinoline (23) compared to isoquinoline (22), ligand 23 has 
almost the same relative luminescence yield ion as ligand 2 2  with the europium ion, yet 
3,3'-bis-isoquinoline (26) is nearly ten times stronger. Since the emission decay constants 
of the chelates 2 2  and 26 are almost the same, the difference in their relative yields must 
be due to the aromatic pait of the complexes,
A ACO2H CO2H CO2H CO2H
(1 )R 1= R 2= H (11) R i=  4-COOH, R2= 4 '-C 00H
(2) R i=  4 -NO2 , R2“  4'-Me (12) R i=  3-PhCOOH, R2= 3'-PhC 00H
(3) R%= 4 -NO2 , R2= H (13) R i=  4-Ph, R2= 4 ’-Ph
(4) R%= 4 -NO2 , R2= 4 -NO2 (14) R i=  4-(4-MeOC6H4), R%= 4'-(4-M EOC6H^)
(5 )R i= 4 -E tO ,R 2 = H (15) R%= 4-(fiir-2-yl), R 2=  4'-(flir-2-yl)
(6) R i=  4-EtO, R2= 4 ’-EtO (16) R i=  4-(PhCH=CH), R2= 4'-(PhCH=CH)
(7) Rj = 4-Br, R2= H (17) R i= R 2=N,N'-dioxide
(8) R i=  4-Br, R2= 4'-Br (18) R |=  4 -NH2 , R2= H
(9 )R i= 5 -B r ,R 2 = H (19) R i= 3 -C 0 0 H , R 2=3'-C 00H
(10) R i=  3-COOEl, R2=3'-COOEt (2 0 )R i =3-O H ,R 2=3'-O H
F igure ' 5 Some 2,2'-bipyridine derivatives.
Generally, the luminescent yields of ligands 22-32 and their europium complexes are 
higher than those of their terbium complexes,
13
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Substitution at bipyridine e^xc Eu
3+ Tb3+
(nm) logR Kuet logR kcw
1 uusubstituted 307 5.50 1.70 5.27 0.82
2 4,4'-dimetliYl 310 5.61 1.69 5.51 0.68
3 4-nilro 328 4.12 1.87 2.94 0.71
4 4,4'-diuitio 338 4.14 1.87 weak
5 4-ethoxy 298 5.33 1.72 5.31 0.62
6 4,4'dietlioxv 290 5.11 1.80 5.13 0.67
7 4-bromo 315 5.36 1.76 5.12 0.96
8 4,4'-dibromo 310 5.31 1.86 5.02 1.33
9 5-bromo 320 4.16 1.77 4.50 1.37
10 3,3 '-bis(etboxYcarbonvi) 275 4.31 1.80 weak
11 4,4'-dicarboxy 325 4.42 1.71 3.54 1.59
12 3,3'-bis(benz>4oxv) 292 5.36 1.84 2.38 1.59
13 4,4-diplieuyl 325 5.52 1.73 5.18 1.12
14 4,4'-bis(4-melbo\Tplieiiyl) 325 5.57 1.78 4.84 3.07
15 4,4'-bis(fiir-2-yl) 330 5.32 1.76 2.10 1,50
16 4,4'-dist5'iyl 315 2.95 1.75 2.63 1.11
17 N,N'-dioxide 280 4.72 1.35 3.74 1.11
18 4-ainiiio 290 4.42 1.72 4.62 0.67
19 3,3'-dicarboxy 283 4.90 1.74 2.23 0.63
20 3,3'“diliydroxy 340 3.91 2.64 weak
21 pyridiue 265 4.83 2.48 4.87 0.80
22 isoqumoliiie 324 4.44 2.63 weak
23 beuzyl(f)isoquiiioliiie 355 4.41 2.65 2.35
24 acridine we ilk weak
25 2,2'-bipyridiiie 307 5.50 1.70 5.27 0.82
26 3,3 '-bisisoqiimoliiie 330 5.33 2.75 weak
27 di(pyrid-2-yl)ketoue 272 4.61 1.02 4.51 0.54
28 2,2’-bipyriiiiidiiie 250 5.17 1.96 weak
29 4,4'-bipyriniidiue 290 5.08 1.78 2.27 1.60
30 1,8-naplitliyridüic 312 4.65 3.09 4.50 1.02
31 1,10-pheuauthrolme 272 5.26 1.98 4.71 1.46
32 2.2'.6'.2"-ten)yridine 333 5.94 0.73 5.64 . .  _nJI6 L_
Tab le 3 Some data for lanthanide chelates.
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1.1.5 Encapsulating Ligands.
The aromaticity of groups in sensitizer ligands in any lanthanide complex presents 
problems. Lanthanide ions do not exliibit strong coordinating tendencies towards such 
ligands, especially in aqueous solution, where solvent molecules efficiently compete to 
occupy coordination sites. As a result, lanthanides form extremely unstable chelates, 
dissociation occuring at low concentrations.
Mukhala^^ '^^"  ^ solved the problem by the use of additional chelating groups in suitable 
positions, an excellent example being the use of two (methylenenitrilo) bis-acetic acid 
groups. This has the effect of stabilising the various aromatic chelates.
Lehi#^^ adopted a different approach in the use of encapsulating ligands. The metal ion 
cannot escape its coordination sphere and as a result interactions with external solvent 
molecules are greatly reduced. Lehn and co-workers were the first group to synthesize 
and study the photophysical properties o f cage type ligands and their lanthanide 
complexes. The group studied europium complexes, called ci-yptands, based on two 
ligands 2 2 (Euc221)  (33) and trisbipyridine^^“^  (Eucbpy.byp.byp.)(34) as shown in 
Figure 6 .
= N
(34)
C
(33)
Lanthanide 221 cryptâtesLantlnuiide bpy.bpy.bpy cryptâtes
Figure 6  Lanthanide cryptâtes.
Results obtained for the Euc221 cryptate^^^’^ ’^^*^^  showed that although the cryptand ligand
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shielded the europium ion from interactions with water molecules, the complexes 
displayed poor luminescent properties. This can be explained by the absence o f a 
cliromophore and the presence o f an activated decay pathway involving Ligand-to-Metal 
Charge Transfer (LMCT), which can be obseiwed as absorption bands in the UV region.
In contrast the cryptand Eucbpy.bpy.bpy displays excellent luminescent 
properties^^ '^^ '^^ '^^ '^^ l^ This ligand, containing three 2,2'-bipyridine units, exhibits strong 
absorption bands in the near UV region due to tc-tt* transitions in the bipyridine units.
Excitation to the spin allowed k* ligand centred (LC) level leads to population of the 
luminescent metal centred (MC) f-f level o f the europium ion, via intersystem 
crossing, from the higher energy, lowest spin-forbidden level with reasonably high 
efficiency (10%). The result is a complex capable of efficiently converting UV light 
absorbed by the ligand into visible luminescent light emitted by the lanthanide ion. Even 
at low concentrations in aqueous solutions (10 M), the complex is capable o f c^verting 
1% of the incident UV photons into emitted visible photons. Lelin has termed these 
lanthanide complexes as Light Conversion Molecular Devices.
A comparison o f the lifetimes and quantum yields for both the Eucbpy.bpy.bpy and 
Tbcbpy.bpy.bpy cryptâtes in water and deuterium oxide, has shown that non-radiative 
deactivation via 0 -H  vibrations can still take place. It is estimated that on average -2.5 
water molecules are still coordinated to the encapsulated lanthanide ion. This would 
explain the low values o f the emission quantum yields, which in the case of terbium 
complexes is further aggravated by the presence o f a thermally activated decay pathway 
involving the triplet excited state of the ligand.
In an eflbrt to reduce the non-radiative losses and increase emission quantum yields, 
considerable effort has gone into the synthesis of different encapsulating ligands^^ '^^ '^^ '^^ l^
The results o f photophysical characteristics of the corresponding europium and terbium
16
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complexes has shown the difficulty in predicting how even small variations in ligand 
stmcture will affect the photophysics o f the resulting lanthanide complex.
Studies have shown that both thermally deactivated decay processes involve different 
mechanisms. In europium complexes this process involves the population o f low lying 
LMCT states from the europium ion emitting state, followed by efficient non-radiative 
decay to the ground state. In terbium complexes, the terbium ion excited state 
undergoes back energy transfer to the triplet ligand level before decay to the ground state. 
This only occurs when the triplet excited state of the ligand lies just above the terbium ion 
em itting level, enabling thermal population at room temperature. On the whole, results 
have shown that the non-radiative deactivation due to LMCT states in europium 
complexes are more difficult to suppress than those due to the ligand triplet state in 
terbium complexes,
17
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The Design and Development o f DNA Assays.
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1.2 Introduction.
The discovery of DNA based probes were hailed as a major breakthrough^^l Early hopes 
were that they could be used to detect a number of infections and genetically inherited 
diseases, with applications in paternity cases and criminal cases where genetic material is 
left at the crime scene. The reality of developing a highly specialized product from a 
clinical research tool has proved to be more difficult and expensive than first envisaged.
1.2.1 Assays-An introduction.
The detection and determination o f a specific analyte within a complex matrix forms the 
fundamental basis o f analytical chemisti'y. Qualitative analysis identifies whether an analyte 
is present or not, Quantitative analysis is a more accurate technique and involves the exact 
measurement of the concentration o f the analyte. The determination of an analyte is called 
an assay. Combinations o f methods are often used in the overall determination of an 
analyte, depending on the nature and complexity of the sample.
Physical methods, such as spectroscopic procedures including Nuclear Magnetic 
Resonance, Mass Spectrometry, Infra Red etc., in conjunction with chromatographic 
separation methods including Gas Chromatography, High Performance Liquid 
Chromatography etc., are commonly used to identify the components o f complex 
mixtures. Alternatively, chemical methods, such as the preparation of derivatives which 
may be isolated and identified easily, can be employed.
These methods have been routinely used in the determination o f analytes at reasonable 
concentration levels > 10“^ M. Difficulties arise when analytes fall below this concentration 
level.
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1.2.2 Molecular Recognition and Labelling.
Prior to the 1960's, routine determination o f analytes at concentrations below 10‘^  M  in 
solution was virtually impossible. Scientists often relied on deduction, experience and 
indirect inferences for answers. A few analytes could be detected by measurable emissive 
processes such as nuclear radiation (oc, p particles and y rays) or luminescence 
(fluorescence and phosphorescence).
New techniques and improvements were rapidly discovered. With the invention of 
photomultipliers, charge-coupled detectors and advances in computer technologies, single 
photons could be detected. By coupling new technologies with classical analytical 
methods the range and concentration levels o f analytes could be extended e.g. a non- 
fluorescent molecule could be detennined after conversion with a non-fluorescent reagent 
to a fluorescent derivative. Unfortunately, this rather simplistic idea is not generally 
applicable.
An improvement on the previous idea would be to use a reagent containing a fluorescent 
group or "label", which would react with the non-fluorescent analyte molecule and 
increase the sensitivity of the deteraiination, rather than relying on the analyte alone. This 
idea presents some problems and in order for it to be viable the analyte must be labelled 
with liigh specificity. The label must not react with any other components in the sample. 
Chemically, this is difficult to achieve, as most reactions are not that specific.
Molecular recognition involves the formation o f complexes between analyte "targets" and 
reagent "probes". Bonding in complexes is strong, highly specific and very selective, 
something which is very difficult to achieve by chemical means alone. These process are 
widespread in living organisms. All biochemical pathways involve a molecular recognition 
process at some point e.g. the binding of an antibody to its target antigen or the 
interaction o f specific enzymes with proteins and amino acids. The incorporation of 
moleculai* recognition processes coupled with chemical labelling techniques would enable
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the accurate determination o f specific analytes in complicated matrices.
A simple model for an assay would consist o f three components;
1 ) The analyte or target.
2) The reagent or probe which recognises and binds specifically to the target.
3) The highly sensitive reporter group or label which allows the specific accurate
detection o f the target-probe complex or conjugate.
The label may be attached directly to the probe reagent, where the concentration o f the 
analyte is proportional to the amount of target-probe conjugate (a non-competitive assay). 
The label can also be added to a known concentration o f target molecules, where the 
labelled reagent competes with the target for binding to the probe and the concentration 
of the analyte is inversely proportional to the amount of labelled target-probe conjugate 
(a competitive assay). Both formats are shown in Figure 1.
ET P
Figure 1 A Non-competitive assay format.
B Competitive assay format.
T=Target F=Probe R=Reporter Group
The first reported assay of this type was developed by Yalow*^  ^ in 1960. The technique 
relied upon the immunological reaction between the analyte to be measured in blood 
serum (antigen) and a specific labelled probe (antibody). The system used the
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radionuclides and as labels and could be adapted to both competitive and non­
competitive assay formats, depending on whether the antigen or antibody was 
radioactively labelled.
This radioimmunoassay (RIA) allowed for the first time the detection of substances, 
including thyroxine and insulin^^*, in blood serum at concentrations very much less than 
10‘^ M. The promising results led to the widespread adoption o f RIA's for the routine 
detection of biological analytes.
A dvantages D isadvantages
1. High sensitivity. 1. Hazardous to health.
2. Unaffected by pH, temperature etc. 2. Limited shelf life.
3. Extremely precise. 3. Automation is difficult.
4. No background signal from reagents. 4. Require special licensing and disposal.
Table 1 The advantages and disadvantages of Radioisotopically based 
Immunoassays.
RIAs offer precision, high detection sensitivities and their activity is independent o f pH 
and temperature, but these are outweighed by the serious health hazards posed by 
radioactivity. Also the shelf life of RIAs is limited due to radioactive decay and they have 
low specific activity, there is less than one detectable event per radiolabel.
As a result of the increased awareness of the problems associated with radioactivity 
alternative non-radioactive labels have been sought^‘*l Although RIAs are still widely used, 
they are gradually being replaced by non-radio active alternatives; including enzyme 
labelled immunoassays (EIA), fluorescent labelled immunoassays (FIA), chemiluminescent 
immunoassays (CIA) and combinations o f these. Some of these are shown in Tab le 2.
2 2
Review: The Desien and Development o f  DMA Assays.
Label Example Measurement
1. Enz>ine. Horseradisli peroxidase (FIRP). 
Alkaline phosphatase (ALP).
Colourless substrate gives coloured 
product.
2. Fluorescent. Fluorescein and rhodamine. 
Lanthanide chelates.
Fluorescence,
Time Resolved Fluorescence.
3. Cliemilumiuesceut. ; Lumiuols and Acridincs. Oxidation by hydrogen peroxide and 
measurement of light emission.
4. Combinations. Eulianced luminescence.
ALP + Luminescent substiates.
Oxidation of isoluminol by hydrogen 
peroxide/HRP/euhancer.
ALP releases active product from 
substrate.
Table 2 Non-radioisotopic labelling systems.
Enzyme labelled immunoassays (EIAs), comparable in sensitivity to that o f RIAs, have 
been widely adopted. The main disadvantages being the lability of enzymes (dénaturation 
and inhibition) and enzymes must be incubated with substrates prior to measurement.
The use of fluorescent probes^^  ^ in assays (FI As) has aroused the most interest due to the 
high specific activity, there are a high number of events per label. A large number of 
fluorescent molecules (fluorophores) are readily available, with emission ranges covering 
the whole spectrum. Each fluorophore has its own unique, characteristic emission which 
could enable multiple labelling, where several fluorophores are used at one time in the 
same assay. Common molecules used are fluorescein and rhodamine derivatives as shown 
in Figure 2.
Fluorescein measurement is extremely sensitive (10‘^ -10‘^ ° M) and its quantum yield 
approaches unity. The use o f these molecules as labels has been limited due to the high 
background signals caused by light scattering, background fluorescent signals from 
biological molecules and the problem of self quenching.
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N=C=S
CI-
N=C=S
Fluorescein isothiocyanate Rhodamine isothiocyanate )
. N i:
Texas Red
Figure 2 Some fluorescent reporter group molecules.
Scattering causes very liigh background values in immunoassays containing high 
concentrations of proteins. The excitation beam can be scattered from either soluble 
molecules (Rayleigh and Raman scattering), small particles and/or solid phase material 
(Tyndall scattering). Rayleigh and Tyndall scattering have the same wavelength as the 
excitation beam. Scattering interferences are aggravated by the small Stokes shifts (usually 
24-50nm) associated with organic fluorophores.
Background fluorescent signals from biological molecules extend over a wide range of 
wavelengths (300-600nm) and are a major problem due to extensive overlap of their 
emission spectra with many fluorophores.
Another problem with organic fluorophores is the "inner filter" effect, which precludes the 
use of multiple labelling of probes to increase sensitivity. This is caused by the significant 
overlapping of the excitation and emission spectra of many fluorophores resulting in 
energy transfer or self quenching. FIAs are unsuitable for the determination of analytes
24
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below concentration levels o f 10‘^ M,
Luminescent metal chelates, especially the lanthanide elements europium and terbium (as 
discussed in Section 1), are of great interest. These chelates possess unique luminescent 
properties and offer high detection sensitivity, certainly comparable to radioisotopes. 
Lanthanide chelates also exhibit large Stokes' shifts (290nm), so there is no overlap 
between the excitation and emission spectra. They also have very narrow emission spectra 
(lOnm band width). Europium and terbium chelates exhibit extremely long luminescent 
lifetimes, 600-1000ps for europium, compared to 5-100ns for conventional organic 
fluorophores.
1.2.3 Types o f Immunoassay.
Immunoassays can be roughly divided into two types;
1) H eterogeneous Assays.
The commonest type o f assay system. In the majority of cases the reporter label has a 
pennanent, constant activity independent o f its physical environment. The reporter label 
remains unaffected by the presence or absence o f the target-probe interaction. All RIAs 
and most EIAs, FIAs and CIAs are o f this format, these labels are readily available and 
common. The insensitivity to target-probe interaction means that the conjugate can only 
be distinguished from the unbound probe by physical separation. This may involve 
separation by chromatography or gel electrophoresis, or via a format whereby bound 
target-labelled probe is immobilized onto a solid support from solution. Excess, unreacted 
probe is removed by caiehil washing. This separation step is lengthy and requires a skilled 
operator making automation difficult. This type of assay format is known as a 
heterogeneous assay.
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2) Homogeneous assays.
The separation step required by heterogeneous assay formats can lead to inaccuracies. 
Separation steps can be avoided if the target-probe conjugate could be quantified directly 
in solution, in the presence o f unbound probe, allowing easier automation and higher 
throughput o f samples. For this to be possible, it would be necessary for the reporter label 
to be unresponsive in the free probe state, then become highly responsive when the probe 
binds to its target. A positive assay would require a "switcliing action" to activate the label 
upon formation of the target-probe conjugate. Tliis switching action is difficult to achieve 
and as a consequence this type o f assay is seldom used. If developed, this format would 
result in a much quicker, simpler and more accurate assay. The direct determination o f an 
analyte without the need for a separation step is called a homogeneous assay.
1.2.4 Nucleic acid based assays.
The development o f new and sensitive molecular recognition assays using DNA probes 
for the detection and identification of target nucleic acid sequences in a strand of DNA 
has been of primary concern since the early 1980s. At the time it was widely thought that 
DNA probes and nucleic acid assays could be used in a number of applications. The 
detection and determination o f nucleotide sequences in samples of chromosomal DNA 
would be of tremendous importance in the diagnosis of a wide range o f infections such 
as Herpes Simplex, Hepatitis, HIV and Salmonella, as well as genetically inherited 
diseases such as Cystic Fibrosis and Sickle Cell Anaemia. Effective treatment relies on 
early diagnosis o f diseases, especially HIV infection, where viral genetic material in the 
blood serum o f an infected host can precede the presence of antibodies by a number of 
months.
DNA probes are highly specific and will seek out complementary base sequences even 
when contained in extremely complex mixtures. The development of nucleic acid assays 
from clinical research tool into a specialized product has been hindered by several major
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problems.
Firstly, the lack of a sensitive enough detection system. A target sequence may only exist 
once or twice in the genetic material o f each cell. The sequence of interest may only be 
100 nucleotides in length, the human genome is around 3x10^  base pairs. The detection 
of such a low concentration, in the presence o f so many unrelated sequences, requires a 
sensitivity below that o f the best labels available. The problem could be overcome if the 
target sequences could be amplified to detectable levels.
Secondly, the development o f highly selective probes that recognize and bind specific 
nucleotide sequences. Naturally occurring DNA exists as two polynucleotide strands 
bound together in a double helix. The genetic code is a series of organic bases attached 
to a phosphate-sugar backbone. There are four organic bases; the two pyrimidine 
derivatives, cytosine (C) and thymine (T) and the two purine derivatives adenine (A) and 
guanine (G). Single stranded DNA chains "recognize" each other and bind together to 
form the double stranded or duplex conjugate. Tliis occurs because of the strong hydrogen 
bonding that occurs between the two sets o f organic bases. Adenine recognises and binds 
thymine whilst guanine recognises and binds cytosine as shown in Figure 3.
The obvious probe of choice for a sequence o f bases in single strand o f DNA would be 
a single strand of nucleic acid (oligonucleotide), bearing the complementary base 
sequence. Oligonucleotide probes would strongly bind to target sequences with high 
specificity to give target-probe duplex conjugates^^l
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Figure 3 The binding in DNA.
The isolation in large quantities of pure oligonucleotides with known base sequences was, 
until recently, not practical. Methods included the biological manipulation o f natural DNA 
by highly sldlled teclinicians. Biological assays using DNA probes were not possible until 
scientists discovered how to artificially synthesize oligonucleotides in large, usable 
quantities. Wliile tiying to find a solution to tliis problem the serendipitous discovery of 
an amplification technique also solved the detection problem.
1.2.5 The synthesis o f oligonucleotides: The Phosphite Triester M ethod.
Khorana^^^ proposed a route to synthesize oligonucleotides chemically. His work led to 
the development of the Phosphite Triester Method, now used commercially for the rapid 
and efficient synthesis of oligonucleotides on a large scale. The method outlined in F igure 
4.
In the initial stage the first oligonucleotide (N J is protected at all reactive positions except 
the 3'- OH group. The oligonucleotide, via the 3'-OH group, is then bound to a silica 
support and packed into a column using a succinyl binding group. When the 5'-0H  group 
is deprotected, using acetic acid, it can react with a further nucleotide (Ng) containing a
28
Review; The Desisn and Development o f  DNA
phosphoramidite group at its 3' position. The phosphoramidite group is activated, using 
a strong acid (in this case tetrazole), and then attacked by the free hydroxyl group o f the 
bound nucleotide.
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Figure 4 The Phosphite Triester Method for oligonucleotide synthesis
The resulting phosphite triester is then oxidized to the phosphate ester, using aqueous 
iodine solution as the oxidizing agent. Following tliis step, the free hydroxyl group 
positions are capped or blocked from reaction by the addition o f acetic anhydride. 
Deprotection of the 5'-OH group o f the new nucleotide is achieved using acetic acid as
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before, tliis is then reacted with a fiirther nucleotide and the cycle is repeated until all the 
desired nucleotides have been added. Once complete, any unreacted reagents are washed 
away and the final oligonucleotide can be released from its silica support. This method 
also allows for the incorporation o f the various functional groups required for the 
conjugation of reporter labels to the oligonucleotide.
1.2.6 The Polymerase Chain Reaction (PCR) and DNA amplification.
A novel use for synthetic oligonucletides was discovered in the 1980s. Oligonucleotides 
provide an ideal starting point for the replication of longer DNA strands. The binding of 
an oligonucleotide probe to a target strand was followed by extension o f the probe with 
a DNA polymerase enzyme. The target strand acts as a template and a new strand 
complementary to the original target strand is produced.
This procedure led to the discovery o f the Polymerase Chain Reaction (PCR)**’^  ^which 
is a synthetic method used for the amplification of duplex DNA in vitro, totally eliminating 
the need for bacterial nucleic acid manipulation. PCR allows a specific target sequence in 
a longer strand of DNA or other chi omosomal material to be replicated millions of times 
without copying all o f the original DNA. This can be seen in Figure S.
DNA may be amplified using the PCR technique without being extracted from the 
biological sample. It is extremely important to prevent any possible external "foreign" 
DNA e.g from the hairs, tears and saliva o f operators or bacterial sources from 
contaminating the process. PCR involves the dénaturation of a substrate DNA at 95"C, 
Two synthetic oligonucleotides called primers are added, together with the four 
deoxynucleotides as their triphosphate salts, to a solution of a DNA substrate prior to the 
start of the first cycle. Both primers are complementary to opposite target strands 
surrounding the duplex segment requiring amplification. A thermally stable DNA 
polymerase enzyme isolated from the bacteria Thermus Aquations is also required.
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F igure 5 The Polymerase Chain Reaction,
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At the beginning o f the cycle, the mixture is heated to 95®C, to completely denature the 
duplex strand into its single strand components. Tliis is followed by rapid cooling to 50”C, 
enabling the two primers to anneal to their respective target strands. The final process 
involves heating up to 72“C, which allows the polymerase enzyme to extend the primers 
starting from their 3' ends. The new strands are complementary to their respective target 
templates.
First generation copies derived from the original strands have random end points. In the 
next cycle the alternate primer binds to each of these strands and replication occurs in the 
opposite direction, back towards the first primer. Once the second generation chain has 
reached the 5' end it then runs out o f template and chain extension stops. Each of these 
new strands then comprises a primer at the 5' end, the target sequence in the centre and 
a segment complementary to the other primer at its 3' end. All subsequent generations 
then have this structure, so after a total o f n cycles the original DNA is amplified by a 
maximum of 2" times. Thus for 20 cycles, the concentration of the original target sequence 
may be increased up to a maximum o f a million times, providing the replication is 100% 
efficient.
Efficient replication is possible for sequences of approximately 1000 base pairs. PCR is 
important in that it provides a means to incorporate useful frmctionalities into DNA 
copies, via primers, wliich are not present in the original DNA substrate. This technique 
has proved invaluable as it allows all copies to be labelled with either a reporter group, 
haptens for antibody recognition or biotin for binding PCR products to avidin coated 
wells.
Using both the Phosphite Triester Method to synthesize oligonucleotides as probes and 
PCR to  amplify duplex DNA targets, we now have the possibility o f creating efficient, 
highly sensitive assays. Since the discoveiy o f the two techniques, the scope and range of 
DNA assays has boomed. Many variations are now possible; new reporter groups, labels 
and detection methods allow numerous combinations of both homogeneous and
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heterogeneous assays to be performed.
1.2.7 Biotin-Avidin Systems.
The non covalent, highly specific and very strong binding of the water soluble vitamin 
biotin (Vitamin H) to the tetrameric protein avidin (or streptavidin) has become one of the 
most useful tools in DNA hybridisation assays. The affinity (formation) constant for the 
biotin-avidin interaction is amongst the Irighest reported (compared to antibody-
antigen interaction at 10“ -10^^ M ‘^ ).
.1.HN N H
H' ■H
OH  
O
Biotin (Vitamin H)
Biotin covalently bound to a DNA probe or antigen can still bind with high affinity to
avidin. If  the avidin is labelled with a luminescent or enzymatic reporter group the
complex can be used for the direct quantification o f the biotinylated molecule.
The biotin-avidin system offers some distinct advantages;
1) It is a universal detection system; one avidin based reagent can be applied to any 
immunoassay or DNA hybridisation assay using biotinylated reagents.
2) Antibodies and DNA sequences are easily biotinylated without loss o f biological 
activity.
3) The biotinylation process introduces many biotin molecules to DNA sequences or 
antibodies providing a significant amplification factor.
4) Avidin is very stable and usually not deactivated on labelling.
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1.2.8 Heterogeneous Nucleic Acid Assays.
1.2.8.1 Non-Lanthanide based Assays.
Until recently, radioisotopes were by far the commonest label used as reporter groups. 
Assays employing radioisotopes are o f the heterogeneous format and often involve the 
labelling o f the phosphate group with “^P using AT^^P and a polynucleotide kinase 
enzyme.
Wages^ ^®^  used ^^ P labelled oligonucleotide probes as a test for HIV infection. The assay 
involved the PCR amplification o f blood cells and primers designed for the HIV-1 DNA 
target. Products from the amplification were then incubated with radioactively labelled 
probes matching the appropriate target sequences. The complex mixture was then 
separated into its various components by gel electrophoresis and the gel exposed to 
photograpliic film. In all cases tested, a large spot appeared due to excess, unbound probe; 
however those with the HIV infection had a second, smaller spot indicating probe bound 
to its target DNA.
Wages^"^ then compared the sensitivities of radioactively labelled probes to equivalent 
non-radioactive labelled probes. Probes were labelled, either directly or indirectly, with 
alkaline phosphatase enzyme (ALP). During indirect labelling, the oligonucleotide probes 
were labelled with biotin or digoxigenin (DIG); enzyme labelling then followed, using 
streptavidin-ALP or anti-DIG-ALP conjugates respectively. The study showed that non­
radioactive methods gave comparable results to their radioactive counterparts.
Bronstein also directly compared radioactive reporter groups with chemiluminescent 
reporter gioups. The method involved the cleavage of DNA into fragments and separation 
by gel electrophoresis. Resulting fragments were then fixed to a Nylon membrane and then 
assayed for specific target sequences with two sets o f oligonucleotide probes. One set 
were labelled with ^^ P and the second with either ALP or with biotin and then conjugated
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with avidin-ALP. Emissions from the radioactive labelled probes were captured directly 
on film. The ALP labelled probes were soaked in a chemiluminescent solution and then 
em issions were captured on to film. Interestingly, the exposure time for the 
chemiluminescent assay was around 30 minutes compared to the 40 hours required for the 
radioactive assay.
Holodniy's^^^^ paper described a colorimetric assay for the detection o f viral DNA 
following PCR amplification. Blood samples were amplified using PCR, the primer at the 
5' end was labelled with biotin, enabling any PCR products to be bound to avidin coated 
wells. The bound products were incubated with an enzyme (horseradish peroxidase, HRP) 
labelled oligonucleotide probe, containing a complementary sequence to the target strand. 
After washing, the wells were treated wLth a solution o f o-phenylenediamine and hydrogen 
peroxide. A coloured product is formed when HRP is retained by the wells, due to 
positive target-probe binding. An outline of this shown in F igure 6.
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An example of a colorimetric assay for DNA.
Martifr^ *^  ^descnbed the indirect labelling of oligonucleotides with digoxigenin and various
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reporter groups. Indirect labelling methods allow for the interchange o f reporter groups. 
A variety of reporter gi oups were attached by reaction with the appropriately labelled anti 
-DIG antibodies. The antibodies were then conjugated with the fluorescent reporter 
(rhodamine or fluorescein), a colorimetric reporter (HRP) and a chemiluminescent 
reporter (alkaline phosphatase) as outlined in F igure 7.
11111111— ZZH..E)  ^ 11111111
DIG Labelled Probe. Reporter labelled Reporter labelled probeanti-DIG antibody
Figure 7 Indirect labelling of oligonucleotides.
Chehab and KaW^ ^^  described an assay utilizing PCR oligonucleotide primers that were 
themselves labelled with fluorescent dyes. Tliis allows the primers to act as sequence 
specific probes, the target sequence being the one that was complementary to the labelled 
primer. A positive assay would be the annealing o f the primer to its target sequence and 
then subsequent PCR amplification would yield an oligonucleotide product labelled with 
a fluorescent dye. The products were separated using gel electrophoresis, the PCR 
product appearing as a second fluorescent spot. A negative assay would fail to produce 
any amplified product as the primer would be unable to anneal itself to any target.
Different fluorophores exliibit different colours of emission, allowing more than one target 
sequence to be detected simultaneously by using the appropriately labelled primers. I f  the 
PCR products were of different lengths, then gel electrophoresis could be used to separate 
them, each product being a distinct, characteristically coloured, fluorescent band. If  the 
products were o f the same length they would not be separated but would be a colour 
wliich was a combination o f the two individual fluorophore emissions, shown in Figure 
8 .
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Figure 8 A mixed fluorescent assay.
Bannwarth and Schmidt^*^* described the labelling o f an oligonucleotide at the 5' with a 
luminescent metal complex, tris-(phenanthroline) ruthenium (II) via a hydroxyalky 
modified chelate shown in Figure 9. The attachment of this label was made possible by 
the phosphamidite technology previously described.
The use o f ruthenium in this type of assay has a distinct advantage over other 
chemiluminescent reagents in that they have prolonged shelf lives and are stable to 
temperatures over 100"C.
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Figure 9 A luminescent Ruthenium reporter group attached 
using phophoramidite teclmology.
These properties have led to the development o f an electrochemiluminescent assay using 
a ruthenium chelate similar to the one shown above'^^’f The emission o f the chelate being 
excited by an electrochemiluminescent reaction. The advantage of this type o f excitation 
is that there is more precise control over the reaction, eliminating problems caused by the 
addition and mixing o f reagents. The assay is shown overleaf in Figure 10.
The oligonucleotide was labelled at its 5' end using phosphoramidite technology. 
Detection of the appropriate target sequence after PCR was possible by using a biotin 
labelled primer containing the target sequence complementary to the probe. After 
incubation of the probe and amplified product the resulting dual labelled conjugate was 
immobilized on streptavidin coated magnetic beads. The beads were washed and 
suspended in tripropylamine buffer solution. On application of a voltage, luminescence 
was initiated by the oxidation of the ruthenium chelate and the tripropylamine, which 
generated an excited ruthenium chelate (TBR*). Luminescence occurs when the excited 
state returns to the ground state and light is emitted at 620nm. This process is autocatalyic 
resulting in the regeneration o f the original label which can be used many more times. '
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Figure 10 An electrochemiluminescent assay using a Ru(II) chelate.
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Time-Resolved Fluorolmmunoassays fTR-FIAY
The principle o f TR-FIA is to remove any unwanted background fluorescence and 
scattered light caused by biological molecules, such as DNA and serum. The process is 
illustrated in F igure 11.
Excitation )l=340nm
Long-lived Fluorescence
Counting A=613nm
Short-lived Fluorescence
0 Delay Time 400 Counting Time 800 1000
TTMDE ps
Figure 11 Schematic representation o f a time resolved fluorometric cycle.
A small delay is set between the excitation pulse and the measurement of the resulting 
luminescence, Short lived background fluorescence from biological substances is 
effectively removed in less than lOOps, leaving the long lived luminescence signals to be 
measured with high sensitivity. The requirement for the reporter label is that its 
luminescence has a long decay time, a characteristic o f lanthanide chelates.
Leif^^i first suggested the use o f europium chelates, such as Eu (p-diketonates) and Eu 
(1,10-phenanthrolines) as reporter label groups. He attached the chelates to biological 
molecules such as antibodies but incorrectly assumed the chelates would be stable to
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pHand solvent conditions. The labels did show long lived luminescence with excellent 
intensity but were unstable in aqueous environments, a common problem in lanthanide 
chemistry.
There are a number of problems to overcome when using lanthanide chelates as long lived 
luminescent probes;
1) The lanthanide must be sensitized for measurable emission to occur.
2) The resulting chelate complex must be kinetically stable and strongly bound.
3) W ater must be effectively removed from the complex to ensure luminescence 
occurs.
The design criteria for a suitable lanthanide chelate complex are;
1) The sensitizer must bind the lanthanide ion strongly at low concentrations in 
aqueous solutions.
2) The sensitizer should absorb above 300nm, have a high extinction coefficient 
(>10‘*M'^cnT )^ and a high quantum yield (cf) ~ 1).
3) The complex should be soluble in water.
4) The complex should contain groups that will enable the complex to be attached
to biological molecules e.g. DNA and antibodies.
5) The coupling process should neither increase or decrease the immunoreactivity of 
the labelled substances.
The advantages of lanthanide chelates over conventional fluorophores are numerous, 
Excitation o f these chelates w ith U. V, light causes an emission in the visible region with 
a specific, characteristic pattern, depending on the lanthanide ion used. The spectrum 
contains a number of sharp, naiTow peaks and the distance between the excitation and 
em ission spectra is large, therefore no self absorption can occur. Emission intensity is 
approximately linear with concentration providing the chelate is strongly bound.
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Despite the obvious difficulties, two commercially available assays have been developed 
utilizing lanthanide chelates as reporter groups.
1.2.8.3 The LKB TDELFTA^ System
Hemmila^^ '^^^  ^was first to exploit the potential o f lanthanide chelates as labels in assays. 
His group patented the first commercially available heterogeneous assay. After successful 
clinical trials, the assay system was christened "DELFIA" (Dissociation-Enhanced 
Lanthanide Fluorescence ImmunoAssay).
Hemmila overcame the problems of combining good absorption and energy transfer 
properties with a strong chelating capacity by separating the two functions, p-diketonate 
moieties chelate europium and possess sensitization properties but they are unstable in 
aqueous environments.
His novel approach was to utilize P-diketonates as sensitizers, but separate the europium 
labelling and measurement procedures. Non luminescent Eu-EDTA chelates were used 
to label either antigens and antibodies. The assay can be carried out in a non-competitive 
or competitive format on a solid phase system. After the reaction has been completed, part 
of the target-probe conjugate is bound to a solid support. Unbound fractions are removed 
by extensive washing o f the solid surface.
Following separation, the target-probe conjugate was quantified by the release o f 
europium ions from the conjugate into an "enhancement solution", forming a tris(p- 
diketonate) complex. The solution also contains tri-n-octylphosphine oxide, which acts
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F igure 12 Principle o f the DELFIA assay and the formation o f the fluorescent 
product after release o f the europium ion.
as a synergistic agent by saturating the coordination sphere around the europium ion, and 
a micelle-forming detergent. This mixture serves to remove the deactivating effect of 
water optimizing the quantum yield o f the complex. The system is shown in Figure 12.
Hurskainen and Sund^ ^^  ^modified the DELFIA assay to allow for the multiple labelling o f 
oligonucleotides using the following three teclmiques illustrated in Figure 13.
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1 ) The polwmvlamine route: a polyvmylamiue oligomer was reacted with an isothiocyaiiate labelled 
Eu.EDTA chelate, so tliat most of the amino groups m tlie oligomer were labelled. A residual amino 
gioup was then used to couple tliis multiply labelled oligomer to an aminoalkyl oligonucleotide via 
reactive ester tecluiolog}'.
S=C=N— EDTA.EU +
NH, NH2
TT  !>
Reactive ester tedinology
NH, NH NHY  EDTA..E11
S
NH NHY  ‘EDTA.EU
S
2 )  The polyaciv’lic route; this method uses a polyaciylic acid oligomer coimected to an aminoalkyl 
oligonucleotide, producing a new oligonucleotide witli a polyfunctional tail, Amino-Eu.EDTA 
chelates are then linked to the carboxylate groups of the tail via amine groups.
I I I I I M + w -
1-IiN-EDTA.Eu.
— ^  L-U- LJL-UJ,^
CO2H CO2H nH 'O
Polyaciylic Acid
co:„
NH 0 0
.EDTAJEu
3 ) The modified nucleotide route: involves the extension of the 5' end of tlie oligonucleotide with a tail
o f between 50 and 100 modified deoxycjdidines containing aminohexyl groups. These were then 
labelled witli isothiocyanate labelled Eu.EDTA chelates.
T T n( T T T Xç)n
NH,
S=C=N-EDTA.Eu
Tc)„
s
Figure 13 The three methods used for the multiple labelling of oligonucleotides.
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Valet^^^  ^ prepared oligonucleotide probes containing a tail of alternating adenine and 
thym ine bases at the 5' end of the probe sequence. Adenine and thymine bases bond to 
each other in DNA, tliis tail allows the formation of a small segment of duplex 
oligonucleotide at the end of the probe, which in turn is labelled with a psoralen derivative 
containing an aminoalkyl group. The psoralen group, when bound, can intercalate into the 
duplex sequence. Intercalation can be made permanent by U. V. irradiation which induces 
cycloadditions between the psoralen groups and neighbouring DNA bases. A luminescent 
terbium chelate is formed after the aminoalkyl groups are reacted with a mixture o f 
terbium nitrate, diethylenetriaminepentaacetic dianhydride and 4-aminosalicylic acid. This 
method is outlined in F igure 14. By modifying the aminoalkyl chains with poly-L-lysine, 
Valet increased the loading o f terbium to 16 chelates per chain. His work proved that 
ligands can be synthesized chemically that are both chelating and sensitizing.
The multiple labelling o f oligonucleotides with europium was first discussed by 
Lovgren^^'^f Slight modification o f the cytosine nucleotides, within the probe sequence, 
involved the reaction o f the cytosine amino groups with ethylene diamine and sodium 
ttsulfite at pH6. The reaction added an aminoalkyl chain wliich is further modified using 
an isothiocyanate-EDTA.Eu chelate, labelling the oligonucleotide with europium ions. 
Using modified cytosines for labelling weakens the binding of probe and target sequence. 
The melting temperature for the duplex conjugate fell by 0.7°C for every label/100 bases, 
the optimum number reported was 8 labels/100 bases before binding was completely 
disrupted. He reported detection limits of 0.15 x 10'^ ® mol o f target DNA.
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F igure 14 The synthesis o f psoralen labelled oligonucleotides.
The lanthanide EDTA type chelates are very wealdy luminescent and detection requires 
intense excitation via laser sources of the use of an enhancement solution such as the 
DELFIA system. The development o f sensitizing ligands with strong chelating properties 
allowing the direct labelling of probe sequences w ith luminescent chelates is desirable. 
Lelnf^^, as discussed in Section 1, developed tris(bipyridyl) cryptand ligands which gave 
strongly bound and luminescent lanthanide chelates (c[) = 1-5%).
Mathis^ ^^ '"^  ^employed the europium cryptate as a label in his DNA assays. His initial assay 
involved the séparation ofD NA fiagments by electrophoresis and then immobilization o f
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these DNA fragments on a nitrocellulose support. This was then treated with a 
oligonuceotide probe with a biotin label attached. After thorough washing o f the support, 
the probe was conjugated with streptavidin labelled with europium cryptâtes, as shown 
in Figure 15
Immobilised DNA
JwivüvvJwJwvlwJwvJ»vv^ N itrocellu lose-----
Support
B/
 Nitrocellulose-----Support
O
NH
Eu
NH-
1
SA-Eu Cryptate
Teu^
SA
B
/
^WWVVWVWVVVVSfWVWVWVVS^-Nitrocellulose Support
Figure 15 An example o f a europium cryptate labelled assay.
Mathis^“^  ^developed another use for europium cryptâtes in the quantification of PCR 
derived products. The two PCR primers were labelled with biotin and 2,4-dinitrophenol 
respectively. After the amplification process the product was immobilised on a 
streptavidin coated support Detection occurred when an anti-DNP antibody, 
incorporating multiple europium cryptate labels, was introduced. This example is shown 
in Figure 16
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DNP = 2,4-dinitrophenol.
SA = streptavidin.
Figure 16 A second example using Europium cryptate as a label.
1.2.8 4 The CYBERFLIJOR System
As an alternative to the use o f europium as a direct label for assays, it is possible to 
introduce europium chelators into immunoreactants and use an excess of europium to 
form the luminescent complex. After the immunoreaction, removal o f excess europium 
by thorough washing and either a competitive or non-competitive format performed, the 
luminescence o f the europium chelate can be directly measured. The success o f this 
approach depends on finding a suitable europium chelator that fulfils two main criteria, 
stable complex formation and the ability to sensitize the lanthanide. The main chelates 
groups are the P-diketonates and the polycarboxylic acids (EDTA), neither of which can
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alone sensitize lanthanides efficiently.
Diamandis^^^^ and co-workers developed a new europium chelator, 4,7- 
bis(chlorosulfonyl)-l,10-phenanthroline-2,9-dicarboxylic acid (BP CD A), shown in Figure 
17, which is capable of both binding and sensitizing europium.
Ç1 a
0= 8=0 0= 8=0
OHHO
BPDCA
Figure 17 4,7-bis(chlorosulfophenyl)-l,10-phenanthroline-2,9-dicarboxylic acid 
(BCPDA).
Diamandis^^®  ^employed BPDCA as a label on a PCR primer in a DNA assay. After the 
amplification cycles, unextended primers are separated from labelled PCR product by 
agarose gel electrophoresis. The gel is developed by immersion in a europium ion solution, 
the ions eventually diffiise into the gel and are chelated by the BPDCA label. After 
irradiation by UV light, the BPDCA/Eu complex, where present, appears as a luminous 
red band.
Diamandis^^®  ^ has also developed a universal detection system based on streptavidin 
labelled with BPCDA. A typical non-competitive assay is outlined in F igure 18.
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Figure 18 A non-competitive two component immunoassay of an antigen using the 
Cyberfluor system.
Takalo*^ ** developed a series of modified EDTA ligands containing an acetylene group Ar- 
CC-Py. These were then modified further by Mukkala^^^* to H-CC-Py and adapted for use 
in a DNA assay. Oligonucleotide probes were prepared with a tail o f iodinated 
nucleotides, which were coupled to the ligand chelates via a palladium catalysed reaction. 
Multiply labelled probes were prepared using europium, terbium or samarium. The 
simultaneous use of these probes led to the development of a three colour assay system 
for combinations of three different target sequences in DNA samples, illustrated in Figure
19. A fourth biotinylated probe (primer) was also used, which bound to a target sequence 
present on the DNA substrate, for the immobilisation of the DNA in streptavidin coated 
wells as part of the assay procedure Luminescence was measured directly following 
washing and drying.
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Figure 19 A three colour assay format.
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1.2.8.5 Assays for the identification of point mutations.
Point mutations involve the corruption of a single base within an oligonucleotide 
sequence, causing a 'mismatch' in a strand of duplex DNA. Oligonucleotide probes are 
ideally suited for the detection o f such mutations provided the design o f the assay is 
carefully planned.
A point mutation will not prevent two complementary, single DNA strands from 
hybridizing together but cause a 'bubble' effect. This happens because the mismatched base 
pair at the mutated site disrupts the bonding in base pairs surrounding the site and reduces 
the binding affinity o f the two strands.
Hood^^^  ^ discovered that the length o f the strand is important as to how the binding is 
affected. In a long strand o f bases the disaiption is much smaller when compared to a 
shorter strand of bases. Oligonucleotides of 20 bases are long enough to be a unique 
sequence and bind strongly to matched DNA targets but short enough to be significantly 
destabilized by a point mutation mismatch. The size of the disruption also depends on the 
type of mismatch; some like G-A and G-T are only slightly destabilizing, while others like 
A-A, A-C, T-C and T-T are more destabilizing.
Lovegren^ '^^^ exploited the characteristics o f point mutations and short oligonucleotide 
probes in an assay format. DNA from a blood source was amplified using PCR. The 
amplified product was then hybridized with two oligonucleotide probes, matching 
sequences on just one of the product strands. The first probe was biotinylated and bound 
to a sequence some distance fr om the mutation site, enabling the target strand to be 
immobilised on avidin coated wells.
The second probe was much shorter in length and labelled with a non fluorescent 
europium chelate; this probe bound directly over the mutation site. Two versions o f this 
probe were produced, one matched for the normal target and one matched for the mutated
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target. If mutated DNA was present then the mutated probe would bind strongly to the 
immobilised target while the normal probe would bind weakly. A stringent washing 
protocol was developed that would remove any weakly bound probe from the wells yet 
leave any strongly bound completely matched probe. Any remaining probe was then 
quantified using the DELFIA system previously described. This assay is represented in 
Figure 20.
M u ta ted  D N A  Target Biotinylated Streptavidin coated  wells
M -Target
a
Immobilised M -Target
in 1Ù.)
stringent
a
W ashing
M atched  M  probe strongly bound to 
M  Target
M atched M  probe retained 
E u signal h i ^ .
stringent
W ashing
M ism atched N  probe w eakly bound to 
M  Target
M ism atched N  probe removed after w ashing 
E u  signal w eak
Figure 20 A point mutation assay using allele specific oligonucleotide probes.
Hood*^ '^ proposed an alternative format whereby the probe sequence is selected to ensure 
the mutation site is at the end of probe (terminal mismatch). The terminal probe then 
disrupts the extension of the probe by enzymatic processes, in this case DNA ligase. DNA 
ligase joins two oligonucleotides, if they both bind to a target strand, so they lie directly 
adjacent to each other. If a point mutation site is present then the action o f the enzyme is 
blocked and the two oligonucleotides are not joined. In the assay a single stranded target 
was hybridized with two oligonucleotide probes lying adjacent to each other, when bound 
to the target. The site of the suspected mismatch lay at one end o f the probes. One probe
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was labelled with biotin, for binding to avidin coated cells and the other with a suitable 
reporter group (luminescent, chemiluminescent or radioisotopic reagent). When 
hybridized in the presence o f DNA ligase enzyme, the two probes were joined if no 
mismatch was present. Following immobilisation, dénaturation and rigorous washing, the 
probe and reporter group remained attached and a positive signal was observed. 
Conversely, if a mismatch was present, the procedure led to the loss of the probe and 
reporter label and no signal was observed. On replacement of the normal probe with a 
matched mutant probe, the enzyme functioned correctly and a signal was observed as 
expected. This assay is shown in Figure 21.
M utant DNA
DNA Ligase
Probe 1 M utant probe 2
Immobilise.
Denature.
Wash.
0
M utant DNA
;
DNA Ligase
Probe 1 Normal Probe 3
;
Immobilise. 
Denature. 
Wash.
Figure 21 An enzymatic DNA assay for point mutation detection.
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A similar approach was adopted by Chehab '^^* using the enzyme DNA polymerase and 
PCR amplification. The principle was to use the fact that if a primer encounters a 
mismatch near the 3' end then extension by DNA polymerase is blocked. The primers were 
labelled with the fluorophores rhodamine and fluorescein. The PCR substrate was DNA, 
which contains two versions of each. The point mutation could occur in three different 
environments, in neither version (normal DNA), in both versions (homozygous mutant 
DNA) or in one version (heterozygous mutant DNA). These three cases were clearly 
distinguishable as illustrated in Figure 22
M
N
N
M
1— <>■
Nonnal DNA
Mutant DNA
= Fluorescein 
= Rhodamine
Red Fluorescence. Normal DNA
Yellow Fluorescence. Heterozygous Mutant DNA
Green Fluoresence Homozygous Mutant DNA
Figure 22 A PCR based assay for point mutations.
The assay is run as a normal PCR amplification procedure, using both normal and mutant 
versions of the primer for binding over the mutation site. The 3' end o f one primer was 
matched to the normal DNA and labelled with the red fluorophore rhodamine. The 3' end 
o f the other was matched to the mutant DNA and labelled with the green fluorophore 
fluorescein. Only matched primers were extended efficiently during the procedure and 
incorporated into the amplified product, together with the fluorescent labels. After
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completion, the products were separated using centrifugation and the colour o f the 
products were determined by UV irradiation; normal DNA gave red fluorescence, 
homozygous DNA gave green fluorescence and heterozygous DNA gave yellow 
fluorescence i.e. a combination of red and green in equal proportions,
1.2.9 Homogenous Nucleic Acid Assays.
The majority of nucleic acid assays are heterogeneous, in that they rely upon 
immobilization of the oligonucleotide target to a support material, allowing the separation 
of hybridised and unhybridised oligonucleotide probes, so that only labelled probe 
hybridised to the target sequence is measured. Homogeneous or solution-phase 
hybridization assays are not widely used.
These assays rely upon a labelling strategy in which a measurable characteristic o f the 
labelled probe is altered by hybridization o f target and probe. When the probe is 
hybridized and bound to its target, the label is switched on. When the probe is in the free 
state it is switched off. This switching mechanism removes the need for the separation step 
that forms the basis of the heterogeneous assay format, making homogenous assays more 
suitable for automation and faster to perform.
1.2.9.1 DNA intercalators.
Radioisotopes are unaffected by their environment and are unsuitable for homogeneous 
assays. Most fluorescent molecules are also unsuitable for the same reason and the high 
background signals associated with that class o f compound. Some fluorescent molecules 
are affected by their environment, certain planar aromatic molecules are capable of 
complexing with double stranded DNA by intercalating between the base pairs o f the 
double helix. 'Intercalators' stay in place by -K-n stacking interactions with the DNA 
bases^^^l Examples are shown in Figure 22.
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Figure 22 Some common intercalators.
The aromatic nitrogens have a permanent positive charge due to quaternization which 
promotes intercalation with the negatively charged duplex DNA. Intercalation of 
fluorescent molecules reduces their fluorescent efficiency (hypochromicity) and this is 
often accompanied by a shift o f the emission maximum to longer wavelengths 
(bathochromicity), Incorporation o f intercalators is often used as a test for the presence 
of duplex DNA, formed when an oligonucleotide probe binds to a single stranded target 
This is shown in Figure 23
hv hv
—
-..... ^  ^
hv '
1Duplex DNA Intercalator 
Figure 23 Interaction ofD N A  and an intercalator
hv"
hv" <  hv '
Complex
If the intercalator is attached to the probe, then intercalation can become an efficient
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intramolecular reaction, as opposed to the less efficient, intermolecular interaction with 
non target duplex DNA. This idea is presented in Figure 24.
Target DNA
Hybridization
Intercalatorprobe Target-probeconjugate
Intercalation
Complex formed on intercalation of fluorophore
Figure 24 An assay utilizing a fluorescent intercalator as a probe label.
Hélène^^ ’^ adopted a similar approach. A short synthetic oligonucleotide comprised solely 
o f thymidine bases was linked to an amino acridine intercalator via a pentamethylene 
attached to its 3' end. Observations confirmed that binding only occurred to nucleic acid 
strands comprising adenosine bases only, as expected. This was proved by the reduction 
o f the fluorescent signal and a significant shift in the emission maximum of the 
aminoacridine label, confirming the presence of duplex DNA by intercalation. Experiments
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also showed that the conjugate was more stable when the intercalator was present. 
Hélène^^*’ in a later paper confirmed the recognition o f a natural sequence ofD N A  by this 
method.
McO
N+-M e
Oligonucleotide probe consisting 
of thymidine bases Aminoacridine intercalator
Figure 25ow An oligonucleotide probe labelled with an 
intercalator.
Arnold*^ '^ utilized acridinium esters as intercalators in a chemiluminescent assay. 
Acridinium esters are also chemiluminescent, but the chemiluminescent property is 
dependent upon the ester functionality. If  the ester group is remove by hydrolysis in 
alkaline solution then the resulting carboxylate group is not chemiluminescent Arnold 
discovered that this hydrolysis is blocked when the acridinium moiety intercalates into 
duplex DNA.
Labelled probe was hybridized with single stranded RNA or denatured DNA for 5-10 
minutes at 60°C. If  any target is present then it hybridizes with the probe and the 
acridinium ester intercalated into the duplex conjugate. Hydrolysis was performed at pH 
7-8.5 in a bufiered alkaline solution, followed by incubation for 10 minutes at 60®C. This 
also serves to deactivate free probe leaving intercalated labels unaffected. When 
incubation is complete, addition of alkaline hydrogen peroxide produces a 
chemiluminescent response from bound probe only. The assay is shown in Figure 25\>.
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Figure 25b The chemistry o f a chemiluminescent assay.
Barton^^^' '^^ utilized a ruthenium dipyridophenazine (DPPZ) complex (Figure 26) in a 
homogeneous assay which also relied on intercalation properties. Ruthenium chelates o f 
bipyridines and phenanthrolines are normally highly luminescent in aqueous solution, but 
chelates incorporating DPPZ were not. This was due to deactivation o f the excited state 
complex by non-radiative process, involving the interaction of water and the phenazine 
nitrogens. Once the chelate intercalates into duplex DNA, luminescence occurs as the 
chelate is efficiently shielded from water, as shown in Figure 27.
,N,N
N'N
Figure 26 A oligonucleotide labelled with a Ru DPPZ chelate.
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Figure 27 An assay utilizing a ruthenium chelate intercalator.
The coupling o f a Ru DPPZ chelate to an oligonucleotide is shown in Figure 27, creates 
an interesting possibility. If  the labelled probe was incubated with single stranded DNA 
substrates, then the probe would only bind to those substrates that contained its target 
sequence. When such a match occurred then the chelate can intercalate in the resulting 
target-probe duplex via the DPPZ ligand and a luminescent signal is observed. When the 
assay was carried out using completely mismatched target DNA then as expected, no 
luminescent signal was observed. This is a prime example of a luminescent "switch".
Intercalation based assays are sensitive to the presence of point mutations. A point 
mutation will have a major effect if the mutation site lies at or near the preferred point of 
intercalation in the target-probe duplex. Disruption of the duplex at this point seriously 
affects the intercalator binding, resulting in a much lower luminescent signal. 
Unfortunately a major disadvantage o f this type o f assay is the unreliable results obtained 
when a large quantity o f unrelated duplex DNA is present. This tends to cause 
intermolecular binding of the intercalator label into the unrelated duplex and a higher than 
normal background signal is observed. This could lead to false positive results.
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1.2.9.2 FRET based assays.
Fluorescence Resonance Energy Transfer (FRET)*"^ ^^ , sometimes called Forster Resonance 
Energy Transfer offers the possibility for detecting nucleic acid hybridization in a 
homogeneous assay format. Forster transfer o f energy occurs by a dipole-dipole induced 
mechanism and does not require direct chemical bonding. The transfer can also occur over 
a relatively long distance (50-100Â). The process requires two species; an energy donor 
and an energy acceptor. The donor is generally a fluorophore, which absorbs short 
wavelength light and fluoresces at a medium wavelength. The acceptor is a molecule 
which can accept the energy of the excited donor. If this "transfer" occurs then the 
acceptor becomes excited, while the donor relaxes back to the ground state without 
emitting. A condition o f the transfer is that there is significant overlap of the donor's 
emission spectrum with the absorption spectrum of the acceptor, tliis "resonance" 
condition gives rise to the name of the process. Once excited, the acceptor can relax back 
to its ground state in one of two ways; by fluorescent emission at a longer wavelength or 
by non-radiative processes (often called a quencher). Energy transfer is only ever efficient 
over short distances, falling off rapidly as the separation between donor and acceptor 
increases. This sensitivity to distance provides the means o f creating a switch for use in 
a homogeneous assay format.
ZamecniW"^^ described three possible approaches utilizing the FRET processes and are 
illustrated in Figure 28. In all cases, target-probe binding led to close placement o f the 
donor and acceptor molecules. A positive result is a reduction in the emission o f the donor 
molecule, while the emission of the acceptor was significantly enhanced. A negative result 
led to donor emission only.
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Figure 28 Three types o f FRET based DNA assay formats.
utilized luminescent lanthanide chelates (Carbostyril 124 as the sensitizer, 
linked to DPTA) as donor molecules and an organic dye as an acceptor molecule Energy 
was transferred between the two molecules when bound together in a positive assay, 
leading to observed long lived fluorescence from the acceptor The acceptor would 
normally have a much shorter lifetime. Selvin called this property LRET (Luminescence 
Resonance Energy Transfer) or DEFRET (DElayed Fluorescence Energy Transfer) The 
chelate is outlined in Figure 29
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re 29 An LRET assay using a lanthanide chelate donor.
Morrison"^ "^^  ^ developed a competitive assay based on the donor/quencher format. Two 
oligonucleotide probes with complementary sequences, one labelled at the 5' end with a 
donor molecule (fluorescein in tliis case) and the other labelled at its 3' end with a non 
emitting quencher (3'-pyrenebutyrate or sulforhodamine 101). In the absence o f a duplex 
target the two probes hybridized with each other, bringing the quencher into close 
proximity to the donor, preventing fluorescein emission. On the addition of duplex target 
followed by dénaturation and hybridization with the probes, the probe strands were 
sufficiently separated, as they had annealed with their respective target sequences, to 
prevent energy transfer to the quencher and fluorescein emission was observed. Emission 
increased with increasing target concentration. This is shown in Figure 30.
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1.2.9.3 Luminescent Enhancement Methods.
Oser and Valet^^^’^ ^^ , as shown in the previous section, utilized a luminescent terbium 
chelate prepared by chemically linldng a 4-aminosalicylic acid sensitizer (which does not 
fonn a terbium chelate on its own) to a wealdy luminescent but tightly bound Tb-DPTA 
chelate in a heterogeneous assay format.
Selvin^ '*'^ "^ ^^  used a similar chelate in his LRET assay (Figure 29), the sensitizer being 
carbostyril 124, which is again a weak chelator. In order to generate a strongly bound 
liiglily luminescent chelate, the sensitizer was tethered to the Ln.DTP A chelate, converting 
their weak intermolecular association into an efficient intramolecular association.Direct 
linkage by chemical means is not the only solution to the use o f these molecules in an 
assay format. The process for converting weak intermolecular binding into an efficient 
intramolecular one can be compared to a light switch in a homogeneous assay. This could
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be achieved using two probes one labelled with a strongly bound, non luminescent 
lanthanide chelate and the other with a sensitizing ligand. Intermolecular binding is then 
an advantage, in that the probes would not efficiently associate together in dilute 
conditions, and little or no luminescent signal would be obseiwed. On addition o f the 
target strand the probes become bound in close proximity to each other. This allows the 
two labels to interact efficiently in a intramolecular association and produce a strong 
luminescent signal upon excitation,
Valet*^ "'®^  has exploited this fact in a homogeneous assay format. The assay used two 
oligonucleotide probes, targeting adjacent sequences on the same strand o f DNA 
substrate. One probe was labelled with non luminescent Tb.DPTA, the other with the 
sensitizer 4 aminosalicylic acid, outlined in Figure 31.
In a positive assay the two oligonucleotides bound to the target strand in such a way that 
then labels were held adjacent to each other and intramolecular binding occurred to give 
a strong luminescent signal, in a negative assay the only signal observed came from the 
intermolecular interaction o f the two labels which was much weaker, more importantly, 
the background signal was dependent only on the concentration of the two probes, if these 
concentrations were known then the background signal could be predicted.
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Figure 31 An enhanced luminescence assay format.
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2.1 Introduc tion .
2.1.1 Initial aim.
The overall aim of this project was to design and develop a new, sensitive homogeneous 
assay for the detection of target DNA sequences and point mutations utilizing 
intercalation, hybridization and the unique properties of lanthanide chelates as labels.
Early work involved the pailicular design o f a homogeneous assay using the criteria based 
on previously published homogeneous assay formats. The range of assays has grown in 
the past few years, the majority being o f the heterogeneous format requiring a separation 
step. A number of homogeneous assay systems have been reviewed in Chapter 1. Initial 
efforts concentrated on the work of Oser and Valet^‘\  Hélène^" ,^ Barton^^  ^and Ai nold^^l
Luminescent metal chelates appeared to be the label of choice in the homogeneous assays 
published. Fluorophores, relying on deactivation after intercalation, were deemed too 
insensitive. Chemiluminescent labels produce only one detectable event per label. Metal 
chelates offer a combination o f stability, high sensitivity, multiple events per label and can 
form a switch type action when component parts come together.
The importance of the intercalation in the detection of taiget-probe duplex DNA and point 
mutations contained therein was recognized early on in the project. An assay involving 
intercalator labelled probes alone could not be relied upon due to the generation of false 
positive results as a consequence o f intermolecular intercalation with unrelated duplex 
DNA.
The rules for complementarity in the hybridization of DNA strands are reasonably well 
known and the chances o f mismatches can be estimated and by the use of long enough 
probe strands can be minimized^^l Calculations have shown that the minimum length a 
synthetic oligonucleotide needs be in order to recognize a single specific sequence is 11
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to 15 nucleotides. Synthetic nucleotides can be designed to the correct length and 
recognize, selectively, a target nucleic acid, a prerequisite in the design of DNA assays^ ®^
The enhanced luminescent method employed by Oser and Valet^^\ provided the best 
example o f the controllable switch which is required for a homogeneous assay format. 
They used two probe reagents and a positive result was the generation of a signal due to 
the interaction between them both. A negative result was a very small, if any, but 
quantifiable signal. The result depended entirely on the concentration of the two probes 
and was not affected by other factors, such as the presence o f non-target duplex DNA.
It was envisaged that the general outline for the assay was to utilize two probe reagents, 
which combine to form a luminescent metal chelate reporter group. The probes alone 
being completely inactive. Efficient association would occur only in a positive assay, when 
binding of the two probes would tether their labels close enough to generate a luminescent 
signal.
The first probe would be an oligonucleotide with a base sequence complementary to that 
o f the target. The second probe would be an intercalator/sensitizer that recognized the 
first probe-target duplex. This also allows for the sensitive detection of point mutations 
in the target, depending on the requirement o f the assay being performed.
2.1.2 Europium as the signalling agent.
A review of the chemistry o f europium is presented in Chapter 1, Section 1, The use of 
europium as the signalling agent has many advantages;
1. Luminescence occurs in the visible spectnam after irradiation with U. V. light. The 
difference between excitation and emission or Stokes shift is large (up to 300nm) 
for europium chelates. There is no self quencliing and emission intensity is 
approximately linear.
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2. Long luminescent lifetimes allow time resolved techniques to be employed, 
eliminating any interferences from biological molecules.
3. Narrow, characteristic emission bands again reduce background interferences.
4. Emission lies in the red region, where detectors are most sensitive.
5. The large excitation region makes it possible to increase the specific activity of the 
lanthanide chelate by increasing the excitation energy.
Europium is also preferred to terbium as it can form chelates with a wide range o f ligands. 
Europium chelates also emit at 615nm, this single band being the dominant part of its 
spectrum. Terbium chelates emit over several bands, the main one being at 540nm in the 
green region.
2,1.3 Cooperative L igands.
2.1.3 . 1  Switching on europium.
In aqueous solution europium ions are virtually non-lumiiiescent due to the low 
absorbtivity and efficient non radiative deactivation of the excited states by vibronic 
coupling to 0-H  bonds in wated^’*^ .The requirement for luminescence is a powerful laser 
source or chelation of the europium ion to a sensitizing ligand, which absorbs in the U. V 
and transfers its energy to the metal ion via the triplet state with high efficiency. This is 
called the "antenna etfecf'^^l Chelation of a sensitizer also reduces the number of 
coordinated water molecules around the metal. The intensity of emission and the lifetime 
o f europium emission increases as the number of coordinated water molecules 
decreases^^®l It is this interaction that can form the basis of the switching action required 
for a homogeneous format, Sensitizing ligands for europium include 13-diketonates, 
salicylates and numerous nitrogen heterocycles.
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2.1.3.2 Tethering ligands.
A requirement of our assay is the attachment (tethering) of the europium ion to one of the 
assay probes. This tether would be a second ligand and would bind europium irreversibly 
to the probe, without sensitizing luminescence or saturating the coordination sphere o f the 
metal ion. This property would then allow for the sensitizing ligand to still bind.
Oser and Valet^^  ^ utilized a derivative of diethylenetriaminepentaacetic acid (DPTA), 
linked via an amide group to the oligonucleotide probe. Similar types of ligand such as aza 
crown ethers e.g. 221-Diacid and ethylenediaminetetraacetic acid (EDTA) have also been 
employed. These ligands can bind europium strongly but they do not completely fill the 
9 coordination sites available around the europium ion, a very desirable property. 
Examples are shown in F igure 1.
o o o. P o
DPTA EDTA 221-DIACID
Figure 1 Some possible tethers for europium.
It was envisaged that the two ligands act in a cooperative manner, surrounding the 
europium ion, shielding it ffom deactivating water molecules, whilst retaining the ability 
to sensitize europium luminescence, as shown in Figure 2.
The ability to link the ligands to the required probes is important. The first probe is the 
oligonucleotide strand. The tethering agent would be attached via a short, flexible chain. 
The second probe is a duplex DNA intercalator, to which the appropriate sensitizer would 
be attached.
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Probe 1 +
Water molecule
Eu
Tethering ligand. EDTA or similar.
^  Sensitizing ligand
Probe 1 Eu +
Probe 1 Eu
Figure 2 Cooperative ligands eliminating water from europium ion solvent shell
On hybridization with the appropriate target strand in a positive assay, the first probe 
would recognize and bind to it. This would hold the tethered europium chelate near 
duplex DNA, allowing the second probe to intercalate near enough to the europium 
chelate to associate with it. The cooperative intramolecular association o f the two probes 
increases the local concentration o f the components and a strong, luminescent signal is 
only generated at this site.
In a negative assay, the only luminescence observed is the result of a much weaker 
intermolecular association of the two probes. The signal intensity is dependent only on the 
concentration of the two probes in solution. The steps leading to the formation of the
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cooperative, ternary complex around the europium ion, once hybridization has taken place 
is shown in Figure 3.
Target DNA Oligonucleotide probe and tethered europium chelate.
-----  ------
■ 5 h ----------> ■
------ ------
Non-luminescent binary complex.
Intercalator-Sensitizer
Figure 3
Highly luminescent ternary complex.
Proposed scheme for a novel homogeneous assay.
The ideas represented in Figure 3 are a result of numerous experiments^” ’ with various 
tethering/sliielding ligands and sensitizing ligands, culminating in the design of two 
different but cooperative ligands for europium. Each ligand, with its own predetermined 
function would, in aqueous solution, encapsulate the metal ion, replacing its solvent shell 
and therefore preventing deactivation pathways. The overall result being strong europium
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luminescence and in effect an observable switch,
2.1.4 Svnthesis of europium labelled oligonucleotide probes.
Earlier studies^” '^ '^^ ’^ identified the aminopolycarboxylic acid, EDTA and derivatives, as 
the most suitable non-sensitizing ligand for chelation of europium. EDTA forms very 
tightly bound, strong complexes with lanthanide elements and does not saturate the 
lanthanide coordination sphere, leaving 3-4 water molecules coordinated to the binary 1:1 
complex.
Oligonucleotide probes were supplied by Cellmark Diagnostics and latterly Oswel DNA 
Synthesis, and fimctionalized with a aminohexyl group at the 5' end. A general method for 
the attachment of the Eu.EDTA chelate to oligonucleotide probe is outlined in Figure 4.
The 5'-aminohexyl group was reacted at room temperature with a minimum 25 fold excess 
of EDTA dianhydride in lOmM Tris buffer at pH 9.0 for 24hrs. This was followed by the 
addition o f a minimum 25 fold excess o f europium (III) chloride to give the chelate 
derivative.
The chelate was purified by passing the whole solution through a Sephadex G25 column 
(NAP 5) using lOmM Tris/HCl at pH 7.5 as the eluent, taking ca. 1 0 -2 0 pi fractions. The 
collected fractions were individually subjected to U.V. analysis at 260nm, with those 
fractions showing strong absorption at 260nm being combined. The presence of 
tagged europium could be checked with the addition of a sensitizing molecule such as 
PDCA and irradiation with U.V. light to generate lanthanide luminescence (see next 
section). The final concentration probe in the combined fractions was determined by O.D. 
measurements using a Pharmacia Gene-Quant automated analyzer.
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TT
Oligonucleotide probe with aminohexyl Ainction at the 5'end.
V a /O N \ / VN O
Large exeess. 
Ethylenediaminetetraacetic 
dianhydride (EDTA dianhydride)
Water
24hrs O-N
OH
O - P - O NH
Excess
EuCL 0 \
OH
-O -P -O NH
Non-luminescent oligonucleotide probe 
labelled with Eu.EDTA chelate.
Figure 4 Labelling o f oligonucleotide probe with a europium chelate.
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2.15 Identification of Intercalator-Sensitizing ligands.
From earlier work by Coates^"\ Yahioglu*^^  ^and West*'"*', the known compound^'^^ 1,10- 
phenanthroline-2,9-dicarboxylic acid (PDCA (1)), Figure 5, was identified as an excellent 
sensitizer for europium luminescence.
OHOH
O
P D C A (l)
1,10-plienaiitliroline-2,9-dicarbo.x>lic acid
Figure 5 PDCA.
The proposed target for the intercalator/sensitizer is shown in Figure 6  and was based 
again on extensive studies by Coates^"^ and Yahioglu^'"^ and later perfected by West^ "^*(
Linker chain
Br-i
NH
IntercalatorOH OH
Sensitizer
(2)
Figure 6  Target intercalator/sensitizer molecule.
The probe (2) was constructed using three distinct components, each component having
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a unique function. The sensitizing ligand is based on PDCA (1), an excellent europium 
sensitizer. The PDCA moiety is functionalized at the 6  position with a group that allows 
the second component or linker chain to react, which has the function of attaching the 
third component or intercalator molecule to the sensitizer.
2.1.5.1 Synthesis of PDCA (11
c a
—N N—
O
(3) (4)
i. N-chlorosuccinimide, PhCO 2H cat.
CCI4 , reflux, 16hrs.
ii. a. 98% H2SO4 , 90OC, 31us. 
b. H2O, A. 30mins.
iii. a. 98% H2SO4. 90oC, 3hrs, 
b. MeOH, A, 30mins.
iv. NaOH(aq), 5 (PC or H2 0 /Ac0 H/HBr. reflux.
Figure Synthetic route to PDCA (1),
OH ( 1) HO
The sensitizer PDCA (1) was synthesized from neocuproin via the hexachloride (4), as 
was the dimethyl ester (5). The chlorination of neocuproin (3) to the hexachloride was 
performed under acid catalyzed conditions and was developed by West^^^  ^ as an 
improvement to the Newkome method^^^l West improved the previous free radical 
initiated perchlorination by replacing MBPCA with benzoic acid. Using this method did 
not affect the overall yield, after purification through a silica plug and recrystallization 
from chloroform/ethanol the desired product (4) was obtained as colourless cr>^stals in 
95% yield.
The parent diacid PDCA ( 1 ), was obtained from the hexachloride (4) by reaction in 98%
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sulfuric acid at 90”C, followed by addition of water and further heating. The crude diacid 
was purified by recrystallization in aqueous tetrahydrofuran to give the pure diacid ( 1 ) as 
a white microcrystalline solid in 99% yield.
If  methanof is used in the above reaction in place of water then the dimethyl ester (5) 
is obtained as a white solid in 85% yield. Hydrolysis of this ester (5) to PDCA (1) 
occurred either by; heating in dilute aqueous sodium hydroxide or refluxing at pH 4 in an 
aqueous acetic acid/hydrobromic acid mixture.
2.1,6 Synthesis of the first intercalator/seiisitizing probe.
The synthetic route to compound (2) is shown in Figure 8  and starts from the 
commercially available (Lancaster) neocuproin heinihydrate (3) (neocuproin is the trivial 
name for 2 ,9-dimethyl-1 , 1 0 -phenanthroline).
The initial step required the nitration of the neocuproin hemihydrate. The ring atom 
nitrogens presented a problem due to deactivation of the aromatic ring system caused by 
electrophilic aromatic substitution, therefore harsher conditions were required than one 
would normally use. The literature method^^^ for the nitration of 1,10-phenanthroline used 
fuming nitric and sulfuric acids at 140°C. These harsh conditions did give rise to the 
desired nitrated product (6 ) with a small amount of the over oxidized dione product (7).
Separation of these two components was not possible by cliromatographic methods, but 
fractional crystallization from ethanol/chloroform yielded pure samples of (6 ) and (7). The 
problem with separation made it easier to purify the compound afrer the next step.
Chlorination was achieved using literature methods^^^’l  The crude nitration products were 
dissolved in chloroform , prior to dilution with carbon tetrachloride, due to solubility 
problems. The reaction mixture was refluxed overnight with N-chlorosuccinimide and a
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trace o f 3-chloroperoxybenzoic acid (MCPBA) as the initiator. The crude product was 
a m ixture o f nitrohexachloride (9) and dione hexachloride (8 ). These compounds were 
readily separated on silica using 2:1 dichloromethane: 40-60 pet. ether. The desired 
product (9) was a pale yellow/green solid obtained in 7@% yield after recrystallisation 
from ethanol/chloroform. The dione hexachloride (8 ) was obtained as yellow needles in 
1 0 % yield following reciystallization from ethanol.
Conversion o f (9) to the nitrodimethyl ester (10) proceeded via a method reported by 
Newkombe^^^. The hexachloride (9) was heated to 98% sulfuric acid for 3hrs at 90“C. The 
solution was cooled in iced water and pre-dried methanol added with caution. The 
resulting mixture was refluxed for 2 1 irs, then poured into iced water and the product ( 1 0 ) 
precipitated. The crude precipitate was recrystallized from chloroform/methanol to give 
pure ( 1 0 ) as an off-white solid in 80% yield.
The nitro group was then reduced to the amine by a catalytic hydrogen transfer method^^^l 
Compound ( 1 0 ) was dissolved in methanol and 10% palladium on activated carbon added. 
Cyclohexene was used as the hydrogen source. After work up the desired amine was 
isolated as a yellow solid, which was purified by flash chromatography to give the pure 
amino dimethyl ester (11 ) in 95% yield.
The linker chain was added via reaction of (11) with 6 -bromohexanoyl chloride, in 
chloroform using diisopropylethylamine as a base. The reaction was rapid and the desired 
product ( 1 2 ) was isolated and purified by flash chromatography to give the pure amide 
( 1 2 ) in 80% yield.
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NO;
^ = - N CCI3
NO2
—N N-=^
»= -N N-=^
CClj o— —oo — —o
( 10)(9)
NHNH
N-=^N—
—O OH HO(13)
i. f.H2 S0 4 /f.HN0 3 ,1400C, SOmins.
ii. N-chlorosucoinimide, MCPBA, CCI 4 /CHCI3 , refliw, BOmins,
iii. a, 9 8 % H 2 S0 4 , 900C, 3his. 
b. MeOH, reflux, BOmins.
iv. cyclohexene, 10% Pd-C cat., MeOH, reflux, Thrs.
V. 6 -bromohexanoyl chloride, diisopropylethylamine, CHCl 3 , 25
vi. pheuanthridine, 1 2 0  ®C, Bhrs.
vii. PI2 0 /Ac0 PhHBr (pH 4). reflux, 24hrs.
F igure 8  Synthesis of the first sensitizer/intercalator.
The intercalator function, phenanthridine, was joined to the sensitizer via quaternization 
with the bromine on the amide linker chain. Quaternization was performed with an excess 
of phenantliridine, as a neat melt (120®C for 4hrs), the excess phenanthridine acting as a 
solvent. The reaction was closely monitored by t i e. (silica: 10% methanol in chloroform). 
After cooling the resulting glassy mixture was dissolved in chloroform then filtered. The 
solution was then dripped into a large volume of ether, the desired product (13) 
precipitated as an off-white solid. Further precipitation of (13) from ether removed excess 
phenanthridine, to give pure (13) in 90% yield.
Hydrolysis of the methyl ester groups proved difficult due to the number of different 
fiinctionalities within the target compound (2 ). Alkaline hydrolysis was not suitable due 
to the lability of phenanthridinium compounds under alkaline conditions^^^l Acid
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hydrolysis would destroy the amide link. After several attempts, the optimum conditions 
were 241irs reflux in dilute acetic acid with a trace o f hydrobromic acid at pH 4. The crude 
product (2 ) was isolated by decanting the hot solution from the oily residue, followed by 
freeze drying to give an orange powder, Analysis o f the target purity proved difficult. 
Mass spectrometry data suggested the compound was produced along with some trace 
impurities. The impurities were slight and the material was used without further 
purification in luminescent studies.
2.1.7 Synthesis of the second intercalator/synthesizing probe.
The synthesis and characterization o f the first probe (2) highlighted several problems. The 
amide group joining the sensitizer and the intercalator via the linker chain was recognized 
as a weak spot in the molecule. The problem lies in the fact that amides are extremely 
labile in the conditions required for the removal o f the ester groups in the final stage of 
the synthesis of (2 ), the final reaction conditions being so mild that the full cleavage of the 
ester groups was not always achieved. Purification and characterization o f probe molecule 
(2 ) also proved extremely difficult.
The sensitization of europium by (2) was not as efficient as the parent compound PDCA 
( 1 ) during initial fluorometric studies, although sensitization proved to be adequate for our 
requirements. As a result o f these problems we decided to synthesize a probe which would 
be more robust, easier to purify and characterize and a more efficient sensitizer of 
europium luminescence.
2.1.7.1 Bathocuproin and its derivatives.
Another phenathroline type compound readily available as a starting material was 
bathocuproin (14). This compound is the starting point for the Diamandis^"®  ^ sensitizer 
label used in the Cyberfluor immunoassay.
88
Results and Discussion: Svnlhesis.
(14)
CIO2S.
OH HO
Bathocuproin BPDCA
Figure 9
Lilce neocuproin, bathocuproin has no âinctionality available for coupling to a linker chain, 
although the introduction of a functional group to a phenyl ring was expected to be easier 
than the functionalization o f  neocuproin.
Bathocuproin was nitrated under the inilder nitration conditions, using 70% HNO3 in 98% 
H 2 SO4 . As in the synthesis of BPDCA by Diamandis^^°\ two problems arose. A mononitro 
derivative could not be isolated, dinitration occurring readily on both phenyl rings to give 
(17). The other problem being nitration is not regiospecific, ^Hnmi* confirming a complex 
m ixture o f isomeric products. These products could not be separated using 
chromatograpliic techniques and chlorination was performed directly on the mixture.
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N— —N
CI3C CCI:(15) OH HO
,N02
(iv)
N— “ N N—
CI3C CCI(18)(17)
.NH-
N— -=-N N—
O— o— (20)(19)
I. N-chlorosuccinimide, MCPBA cat., CHCl 3 /CCI4 , reflux, 16hrs.
ii. 1. 98% H 2 SO4 ,90OC, 3hrs.; 2 . H2 O, reflux, 30mins.
iii. 70% PINO3 , 9 8 %H2 S0 4 , 0-lQoC, 15mins.
iv. 1. 981o H 2 SO4 , 90°C, 3hrs.; 2. MeOH, reflux, 30mins.
V . cyclohexene/animoniuni formate, 10% Pd-C cat., MeOH.
Figure 10 The synthesis o f some bathocuproin derivatives.
Chlorination of the mixture was achieved under the same conditions used for neocuproin 
series. The procedure as expected gave a mixture of isomers that could not be readily 
separated. The mixed product (18) being used directly in the next step.
Further reactions gave the dinitromethyl ester (19) and the diaminomethyl ester using the 
same methods as for the neocuproin series. Again, isomeric components could not be 
separated.
The unsubstituted diacid (16) was also prepared using the method developed by
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Diamandis^^°^, perchlorination o f bathocuproin gave the hexachloride (15), isolated as a 
white crystalline solid after recrystallization from ethanol/chloroform in 95% yields.
Reaction o f (15) with sulfuric acid at 90”C, followed by the addition of water, gave the 
cm de diacid as a yellow solid. Recrystallization of the crude product from aqueous 
tetrahydrofuran gave the target diacid (16) as a pale yellow solid. Luminescent studies 
showed this compound gave a more intense europium emission than PDCA, however the 
solubility o f the diacid (16) in water was extremely poor. This was a major disadvantage 
if used in aqueous solution, our assay was intended to be water based.
2.1.7.2 Synthesis o f monophenylneocuproin and derivatives.
From the synthetic results so far, it was deemed that neocuproin and bathocuproin were 
not ideal starting points for the synthesis of functionalized sensitizer ligands. Hungarian 
patents^^^’^ ^^  described the synthesis o f bathocuproin from non-phenanthi'oline based 
reagents
+
N—>=-N
(22) (14)(21)
i. KH2ASO4 , c. HCK 8 O0 C, 7hrs.
Figure 11 Synthesis o f bathocuproin.
By modifying these reagents it would be possible to produce more useful derivatives. The 
initial target was the synthesis o f the monophenyl derivative of neocuproin (26). This 
could be achieved if the phenyl group was removed from the quinoline reagent. 
Unfortunately the starting material required 2-methyl-8-aminoquinoline (25), was not 
commercially available, but the nitro precursor was. The synthesis of (26) is shown in 
re 1 .2 .
9 1
(23)
N H ,
(21 )
. beiizene, AlCl 3 , 25°C.
i. cyclohexene/ammonium formate, lOH Pd-C, MeOH.
ii. K H 2 ASO4 , c. HCl, 8Q0C, 7hrs.
—N N—
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(ii)
N O ,
(24)
(26)
Figure 12 Synthesis o f 4-phenylneocuproin.
Crotonyl chloride (23) was prepared from the reaction o f crotonic acid and thionyl 
chloride^"^l The acid chloride was isolated fi'om the reaction mixture by double fractional 
distillation, collecting the fraction boiling in the range 114-118°C, as a colourless liquid.
(23) was then reacted with 1.1 equivalents o f anliydrous aluminium (III) chloride in 
benzene. A vigourous reaction ensued, with HCl gas evolved. The crude mixture 
containing two fractions was separated using cliromatography (silica: 2 : 1  
dichloromethane:40-60 pet. ether). The major fraction being the desired product (21), 
wliich was frirther purified by vacuum distillation to  give a colourless liquid in 79% yield. 
The reagent (25) was prepared from the commercially available 2-methyl-8-nitroquinoline
(24). The starting material was dissolved in chloroform and passed over charcoal, to 
remove impurities, then filtered and evaporated. Reduction o f the nitro group was 
achieved using the catalytic hydrogen transfer reaction using either cyclohexene or 
ammonium formate as the hydrogen source. The desired amine (25) was isolated as a 
yellow solid, which darkened on exposure to air.
Reaction of the propenyl ketone (21) and the amino quinoline (25) was performed under 
the literature conditions, in concentrated hydrochloric acid solvent at 80°C for 8 hrs^^ l^ 
Potassium dihydrogen arsenate (V) was used as the oxidizing agent and a tliree fold 
excess of ketone was used. After the reaction, the organic components were isolated and
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purified by chromatography (silica; 2 : 1  dichloromethane:40-60 pet. ether then pure 
dicliloromethane) to ensure the removal o f unreacted starting materials. The column was 
then flushed with 2-5% methanol in dichloromethane, leaving a dark brown solution, 
containing the desired product (26). The solution was evaporated and the residues 
dissolved in chloroform then diluted with a large volume o f  cold ether. The solution was 
left in the freezer for several days and the desired product (26) ciystallized out in a 65% 
yield.
The 4-phenylneocuproin (26) was derivatized using the same methods as bathocuproin 
(14) and outlined in Figure 13.
-5>
CI3C(26) (28)
HOOH
(Hi)
.NO,
(iv)
—N N ——N
CCI3CtaC(29) (30)
(vi)
^N
O—  (31) — O
—NN— N —
N—
i. N-chlorosuccinitnide, MCPBA cat., CHCl 3 /CCI4 , reflux. 16!irs.
ii. 1. 98% H2 SO4 . 90OC, 3hrs.; 2. H^O, reflux, 30mitis.
iii. 10%  HNO 3 , 9 8 %H2 S0 4 , O-IQOC, I5min.s.
iv. 1. 98% H2 SO4 , 90°C, 3hrs.; 2. MeOH, reflux. 30niins.
V. ammonium formate, 10% Pd-C cat., M eOIl, 25°C .
vi. A c 2 0 , pyridine.
Figure 13 Synthesis o f some 4-phenylneocuproin derivatives.
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Perchlorination using the standard conditions gave the hexachloride (27) as a white 
crystalline solid in 80% yield after recrystallization from ethanol/chloroform. (27) was 
then reacted with 98% sulfuric acid and water in the usual way to give the diacid (28) as 
pale yellow solid in 90% yield after recrystallization from aqueous tetrahydrofuran,
4-phenylneocuproin (26) was readily nitrated using the standard aromatic conditions at 
0°C. This produced the mononitrated product (29) at 95% yield. This compound could 
not be readily purified and was thus perchlorinated directly to give the hexachloride (30), 
which was isolated as a white solid in 90% yield.
This compound was then converted to the nitrodimethyl ester (31) and the aminodimethyl 
ester (32) in 70% and 80% yields respectively. Again the isomers could not be resolved 
but with only one functional group, this represented a major improvement on the 
bathocuproin derivatives.
The amine (32) was converted into the acetamide (34) by warming in pyridine and acetic 
anhydride. Giving the desired product as a white solid in 80% yield.
2.1.7.3 The proposed second probe.
The preparation of 4-phenylneocuproin (26) solved many o f the problems associated with 
the use of bathocuproin (14) and neocuproin (3) derivatives.
(3) 
Neocuproin
(14)
Bathocuproin
(26)
4-phenylncocuproin
F igure 14 Phenanthroline derivatives.
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4-phenylneocuproin (26) has an extended aromatic system leading to the diacid derivatives 
being more efficient sensitizers than their corresponding neocuproin diacid derivatives, 
Monofunctionaiized derivatives were obtainable more readily than with bathocuproin.
The problem of regioselectivity could also be avoided if the phenyl ring o f the propenyl 
ketone reagent were flmctionalized. Based on the work o f West'^ ‘^*^ the new probe (34) 
was identified as shown in Figure 15. This new probe had approximately similar 
dimensions to the first target probe (2 ).
—N
OH HO(34)
Figure IS The second probe.
2.1.7.4 Synthesis of the second probe (34).
The synthetic route to (34) developed by Wesd '^^  ^ is outlined in F igure 16. The 
functionalized linker chain was chosen to be the chloropropyl group, due to its relative 
unreactivit}:. Later in the synthesis the chlorine is exchanged for a more reactive bromine, 
this is necessary to allow quaternization of the intercalator.
3-Chloropropylbenzene (35) was obtained from Aldrich and used directly in a Friedel- 
Crafts reaction with crotonyl chloride (23) and aluminium (HI) chloride in 
dichloromethane. The mixture was evaporated and a dark brown residue remained. The 
major product was isolated after flash cliromatography (silica; 2 : 1  dichloromethane:40-60
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pet. ether) and crystalized horn cold ether. The pure ketone (36) was obtained as a white, 
waxy solid in 40% yield.
The ketone (36) was reacted with 2-methyl-8-aminoquinoline (25) and potassium 
dihydrogen arsenate (V) in a mixture of conc. hydrochloric acid and co-solvent acetic acid 
at 90°C for 301irs, The crude mixture containing several fractions was separated using 
chromatography (silica: 2:1 dichloromethane:40-60 pet ether). The pure phenanthroline 
product (37) was crystallized from cold ether/cliloroform as brown crystals in a 55% yield.
o
O—  (39) — O
(40) °
N—
OH HO(34)
i. AICI3 , CH2 CI2 , 230C.
it. KH2 ASO4 , c.HCi/AcOH, 90OC, 30hrs.
iii. NCS, MCPBA cat., CCI4 , CHCI3 , reflux, I6 brs.
iv, 1. 98% H2 SO4 , 90°C. 3hrs; 2. MeOH, reflux, 30tnm.s. 
V. Halogen exchange, sodium bromide, mellianol.
vi. Phenantlu-idine, 120 °C.
vii. H"^ , H2 O, reflux.
Figure 16 Synthesis of second probe (34)
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Reaction of (37) with excess N-chlorosuccinimide using MCPBA as a catalyst was 
conducted under the standard conditions. The perchlorinated product (38) was obtained 
as white crystals in 90% yield.
(38) was converted to the dimethyl ester (39) by reaction with formic acid and water, then 
acidified methanol. The dimethyl ester (39) was recrystallized from chloroform/methanol 
and obtained in a 70% yield.
The chloropropyl chlorine chain was exchanged for bromine by reacting (39) with sodium 
brom ide in refiuxing methanol to give a bromopropyl chain (40). Compound (40) was 
quatemized with phenantliridine, using the same conditions as in the synthesis o f the first 
probe to give the quatem ized compound (41).
The ester groups of (41) were hydrolysed in aqueous formic acid/HBr. A solid 
precipitated out on cooling which proved, when characterized, to be the target compound 
(34).
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2.2 Introduc tion.
Having designed, produced and rigorously tested the necessaiy components^^^ 'work now 
focused on the final assay and refinement of the procedures and protocols developed. Our 
overall aim being the detection of target DNA sequences and point mutations in a much 
longer strand o f DNA using intercalation, hybridization and the unique luminescent 
properties o f the lanthanide elements. The proposed format o f the assay can be seen in 
Figure 1.
Eu
Target DNA Oligonucleotide probe and tethered europium chelate.
Non-Iuminescent binary complex.
r
Intercalator-Sensitizer
Highly luminescent ternary complex.
F igure 1 Proposed format o f the assay.
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2.2.1 The structure o f DNA.
Since the double helical structure of DNA was first described by Watson and Crick^^  ^in 
1953, it has been shown that the double stranded polynucleotides can adopt a number of 
conformations^^! These helical conformations are grouped into three distinct forms; A, B 
and Z forms. A and B are right handed whereas the Z form is left handed.
Each conformation involves a helix made up o f two anti-parallel polymer strands with the 
bases paired through W-C hydrogen bonding. The shapes of the molecules are quite 
different and are shown in Figure 2.
'  Z - D N A
B - D N A
major
groove
major
groove
minor
groove
minorg roove
A - D N A
Figure 2 The three structural forms o f DNA.
groove
The predom inant B form is a regular right handed helix, with base pairs oriented 
essentially perpendicular to the helix and regular well defined major and minor grooves. 
Major grooves are wider than their minor groove counterparts, both being of equal depth.
The A form on the other hand has a deep, narrow major groove which is virtually 
inaccessible to binding by other molecules and a shallow but wide minor groove The base
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pairs are tilted and pulled away from the helix axis, so that the polymer has a cylindrical 
hole running down its middle. The overall effect being a ribbon-like stmcture wrapped 
around a pole.
The Z form is a left handed helix with a zig-zag sugar phosphate backbone, which is 
adopted mostly by alternating cytosine/guanine sequences. It has a very deep and narrow 
minor groove with an almost non existent major groove, making it impossible for 
intercalating agents to bind to Z-DNA.
2.2,2 The interaction o f small molecules with nucleic acid.
One o f the prerequisites of our assay involved the use of intercalation. The use of 
intercalation would provide good discrimination between hybridized and unhybridized 
probes caused by the local concentration effect of the sensitizer near bound europium in 
the hybridized species.
Molecules interact with duplex nucleic acids in three very unique ways;
1. External binding can occur along the exterior of the helix through interactions 
which are generally non-specific and electrostatic in origin.
2. Groove binding interactions which involve direct interactions of the bound 
molecule with the edges o f the base pairs in either o f the major or minor grooves 
o f the helix.
3. Intercalation o f some planar aromatic ring systems between the base pairs.
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External Electrostatic. Groove Binding. Intercalation.
F igure 3 The three primary binding modes in DNA.
The hi st two binding modes do not require a nucleic acid conformational change but may 
induce structural transitions on complex formation. Intercalation requires a change in the 
sugar-phosphate chain torsional angles for separation of adjacent base pairs by a distance 
sufficient to allow insertion o f the intercalating molecule, typically 3.4Â. This can be 
accompanied by other changes in the helical parameters such as unwinding and bending. 
These modes of binding are shown in F igure 3.
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Typical molecules and ions that bind to DNA by the various modes are shown in Figure
4.
1, External electrostatic interactions; Na
2, Groove binding; Netropsin cH. 3. Intercalation; Acridine orange hydrochlorideCHj O jj N ^ '
o ff
HCf
Figure 4 Some typical molecules that bind to DNA.
2.2.3 External electrostatic interactions.
Nucleic acids are highly charged polyelectrolytes whose anionic phosphate groups 
strongly affect their structure and interactions''ll DNA is a polyanion, with one negative 
charge for each nucleotide, a total o f two negative charges for each step along the helix. 
The helical column is bathed in negative charges and to exist in stable conformations it 
must sequester cations ifrom solution. Manning^^  ^has shown that simple ions such as alkali 
metal ions associate with nucleic acids largely as a function of the polymer charge density. 
The association of ions w ith a polyelectrolyte is called counter-ion condensation and 
causes an unfavourable entropy term in the overall polymer conformational free energy 
summation, This unfavourable tenn is more than outweighed by the numerous favourable 
interactions in a folded polymer, such as the DNA double helix. Partial release of these 
cations on dénaturation and processes like hybridization or binding to specific nucleic acid 
sites ai e highly dependent on 'salt' concentrations. Multiply charged cations such as Mg^^ 
and cations of simple organic amines such as 1,3-diaminopropane interact with DNA more 
strongly than singly charged cations such as Na"" or IC and to such an extent as to cause 
displacement of the singly charged cations^^ l^
W ater is also bound to the exterior of nucleic acid structures and interacts with polar 
groups on the bases and sugars as well as with the charged phosphate groups. These
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interactions are essential for the maintenance of stable nucleic acid conformations.
2.2.4 Groove binding molecules.
The electrostatic potential, hydrogen-bonding, steric effects and hydration o f major and 
minor grooves varies significantly. Many protein and oligonucleotide molecules exhibit 
binding specificity primarily through major groove interactions, whereas small molecules 
prefer the minor groove. Typical minor groove binding molecules share similar structural 
characteristics such as simple aromatic rings like fiiran, benzene or pyrrole, all connected 
by bonds with torsional freedom. This results in crescent shaped molecules, which with 
the appropriate twist, can fit into the helical curve o f the minor groove with the 
displacement of water from the groove. The interior of the crescent shape tends to contain 
molecules with hydrogen bonding N-H groups. These groups form hydrogen bonds with 
A-T base pairs in the minor groove but are excluded from similar interactions with G-C 
base pairs by the amino group o f the guanine^’l
2.2.5 Intercalating molecules.
Lermans^^^ X-ray diffraction and hydrodynamic studies on the proflavine-DNA complex 
laid the foundations for the intercalative mode of binding in nucleic acids. His proposal 
was that the planar proflavine molecule inserts between the base pairs of duplex DNA.
The following changes occur in the nucleic acid up on intercalation^’^
1. Unwinding and lengthening o f the DNA helix in order to accommodate the 
intercalator, due to untwisting of the base pairs and the helical backbone. 
Intercalation produces an extension of 3.4Â and serves to stiffen the helix.
2. Electronic interactions between the intercalator and the base pairs. Intercalation 
results in an ordered stacking of the bound species between the base pairs o f 3 .4Â
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separation. The intercalating surface is sandwiched tightly between the aromatic 
base pairs and stabilized electronically in the helix by Tc-n stacking and dipole- 
dipole interactions.
3. Rigidity and orientation o f the intercalator within the DNA helix. Upon 
intercalation at the unwound site there is substantial overlap between the base pairs 
and the intercalator. The intercalator becomes rigidly held and oriented with the 
planar moiety perpendicular to the helical axis.
The above physical and electronic changes form the basis o f experimental methods used 
to establish whether intercalation has taken place or not.
Many planai' charged polycyclic aromatic compounds have been shown to intercalate with 
DNA. They generally contain a planar chromophore with two to four rings, the optimum 
being three, several groups available for hydrogen bonding and a overall positive charge^^l 
Typical binding constant for these types o f molecules are lO^-lO^mol'Mm^^^^l Some 
typical intercalators are shown in Figure 22, Chapter 1, Section 2, page 57.
The problem with intercalative binding is that many so called intercalators have been 
found to groove bind also^“ l  The factors which determine which mode of binding 
predominates. It is commonly thought that surface or groove binding is the first step 
towards intercalation. Temperature-jump relaxation measurements have shown that 
proflavine intercalates via a mechanism involving initial fast bimolecular attacliment to the 
surface of the helix, followed by one or more slower insertion steps'^^"l Intercalation of 
proflavine does not require preopening o f the duplex^^^  ^and at equilibrium a proportion 
o f the ligand remains externally bound.
Studies with ethidium bromide^ '^*  ^ have shown that a completely different intercalation 
mechanism operates, involving direct intercalation and no externally bound intermediates.
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has studied a newly developed assay for the unwinding of linear DNA and 
provided strong evidence that many simple quatemized phenantliridines and acridines 
adopt an intercalative mode o f  binding.
In terms o f our assay design, we decided to employ phenantliridine or acridine as the 
intercalator, as discussed in the previous synthesis section.
2.2.6 Studies w ith syn thetic oligonucleotides.
2.2.6.1 Introduction.
Our approach to a direct in situ identification o f target DNA strands using a homogenous 
assay format is illustrated in Figure 1, page 99. The probe is linked to a chelator to which 
a europium ion is strongly coordinated. Tliis probe is then hybridized to a single 
complementary target strand of DNA to form a duplex strand of DNA. When tliis 
situation arises and there is no sensitizer present neither the duplex target or its 
components gives a signal when irradiated with light at the sensitizing fr equency. It is 
known that europium has a very weak absorption coefficient since the excitation process 
is formally spin Ibrbidden^^’l
The initial excited state o f europium is only efficiently reached by a ligand to metal 
sensitized energy transfer process involving a triplet sensitizer such as PDCA. Such 
transfer processes require very close contact between sensitizer and the metal ion. We 
have shown in earlier studies that under certain conditions, chelates of europium can 
accept a second ligand such as PDCA, which acts both as a sensitizer and a shielding 
ligand to displace any solvated water molecules, solvated water inhibits europium 
luminescence.
The above effect is the key feature of our assay design; the need for cooperation between 
the europium ion and two different ligands to form a ternary complex or a three
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component cooperative system. In this system, once assembly of the probe and target 
strands are hybridized to for the duplex DNA, the sensitizer is able to approach and bind 
to the already tightly coordinated metal ion.^ ^^ ^
The non sensitizing or tethering ligand, usually EDTA or DPT A needs to  have an 
extremely high binding constant for the europium ion, I O^^mol'  ^dm^. Tliis is so that 
once attached to the oligonucleotide probe, the bound state will be maintained and we can 
consider the Eiri^.EDTA complex as a single, stable entity,
However, the binding constant of the sensitizer for the Eu^^.EDTA should be much 
smaller, A high binding constant would result in the components coming together in bulk 
solution, rather than in the target duplex DNA, leading to high background results. The 
binding constant for the sensitizer for the chelated europium ion is in the order o f 
lO^mol'Mm^, therefore at concentrations below 1 x 10'’M  little association between the 
components occurs. This ensure minimal background counts, which upon further dilution 
was expected to fall away rapidly.
The success of our system relies upon the enhancement o f the signal for europium 
luminescence once the oligonucleotide probe strand has bound to its target strand. This 
enhancement of the signal for europium is achieved by using intercalation and 
sensitization. Intercalation is a characteristic o f duplex DNA and is in the order of 
lO^moHdm^. Intercalation also serves to increase the local concentration o f the sensitizer 
and this occui s in cooperation with the binding constant of the sensitizer to the metal ion. 
As a consequence, the overall binding constant of the sensitizer to the metal ion is 
increased and results in the enhancement of the europium signal. In the presence on target 
strand DNA, europium luminescence is generated in a cooperative, intramolecular manner 
and upon dilution this signal is expected to fall away less rapidly than the background 
intermolecular signal.
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2.1.6.2 Synthesis o f oligonucleotides: The Phosphite Triester Method.
In the initial stage the first oligonucleotide (N J is protected at all reactive positions except 
the 3'- OH group. The oligonucleotide, via the 3'-OH group, is then bound to a silica 
support and packed into a column using a succinyl binding group. When the 5 '-0H  group 
is deprotected, using acetic acid, it can react with a further nucleotide (Nj) containing a 
phosphoramidite group at its 3' position. The phosphoramidite group is activated, using 
a strong acid (in this case tetrazole), and then attacked by the free hydroxyl group of the 
bound nucleotide. The resulting phosphite triester is then oxidized to the phosphate ester, 
using aqueous iodine solution as the oxidizing agent.
Following this step, the free hydroxyl group positions are capped or blocked from reaction 
by the addition o f acetic anhydride. Deprotection of the 5'-OH group o f the new 
nucleotide is achieved using acetic acid as before, this is then reacted with a further 
nucleotide and the cycle is repeated until all the desired nucleotides have been added.
Once complete, any unieacted reagents are washed away and the final oligonucleotide can 
be released from its silica support. This method also allows for the incorporation o f the 
various fiinctional groups required for the conjugation o f reporter labels to the 
oligonucleotide. Tliis method is shown in F igure 5.
108
Results and Discussion: The /Ijjtc/v.
'3' Binding agent Q ' ^
5'Dcprotect 5-O H  /  y------------S- ( NjP )
AcOH
3’ 9
JWWWWWWW»'
5' DMTO
3'
N ,P
?MeO*^  "^ NR-
Tetrazole  î>-HNR2
5' HO.
o ®
DMTO
O
M e O -P
O
. k f )
&o
mnswAmmiVw
Oxidize
l2(aq)
DMTO
O
MeO—P = 0  
O
9MVwWXWwWuW
(i) A c2 0 ------- ÿp
(ii) AcOH
MeO—P - O
n cycles Final dcprotection
--------------------5S> -------------------------------
Release from support
OH
N,
OH
o - f - o
O N,
OH
O - P - O  
O N ,
OH
O — P — O ’M 'V *
O
F igure 5 The Phosphite Triester Method for oligonucleotide synthesis.
2.2.Ô.3 The Polymerase Chain Reaction fPCRl and DNA amplification.
Synthetic oligonucleotides provide an ideal starting point for the replication of longer 
DNA strands. The binding of an oligonucleotide probe to a target strand was followed by 
extension o f the probe with a DNA polymerase enzyme. The target strand acts as a 
template and a new strand complementary to the original target strand is produced.
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This procedure led to the discovery o f the Polymerase Chain Reaction (PCR)^^ '^ °^  ^which 
is a synthetic method used for the amplification of duplex DNA in vitro, totally eliminating 
the need for bacterial nucleic acid manipulation. PGR allows a specific target sequence in 
a longer strand of DNA or other chromosomal material to be replicated millions o f times 
without copying all o f the original DNA. This can be seen in F igure 6.
DNA may be amplified using the PGR technique without being extracted from the 
biological sample. It is extremely important to prevent any possible external "foreign" 
DNA e.g from the hairs, tears and saliva of operators or bacterial sources from 
contaminating the process.
PGR involves the dénaturation o f a substrate DNA at 95°G. Two synthetic 
oligonucleotides called primers are added, together with the four deoxynucleotides as their 
triphosphate salts, to a solution o f a DNA substrate prior to the start o f the first cycle. 
Both primers are complementary to opposite target strands surrounding the duplex 
segment requiring amplification. A thermally stable DNA polymerase enzyme isolated 
from the bacteria Therm us Aquaticus is also required.
At the beginning o f the cycle, the mixture is heated to 95"G, to completely denature the 
duplex strand into its single strand components. Tliis is followed by rapid cooling to SO'^ G, 
enabling the two primers to anneal to their respective target strands. The final process 
involves heating up to 72°C, which allows the polymerase enzyme to extend the primers 
starting from their 3' ends. The new strands are complementary to their respective target 
templates.
First generation copies derived from the original strands have random end points. In the 
next cycle the alternate primer binds to each of these strands and replication occurs in the 
opposite direction, back towards the first primer. As shown in Figure 6.
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F igure 6 The PCR amplification o f oligonucleotides.
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Once the second generation chain has reached the 5' end it then mns out o f template and 
chain extension stops. Each o f these new strands then comprises a primer at the 5' end, 
the target sequence in the centre and a segment complementary to the other primer at its 
3' end. All subsequent generations then have this structure, so after a total o f n cycles the 
original DNA is amplified by a maximum of 2" times. Thus for 20 cycles, the 
concentration of the original target sequence may be increased up to a maximum of a 
million times, providing the replication is 100% efficient.
Efficient replication is possible for sequences o f approximately 1000 base pairs. PCR is 
important in that it provides a means to incorporate useful functionalities into DNA 
copies, via primers, which are not present in the original DNA substrate. This technique 
has proved invaluable as it allows all copies to be labelled with either a reporter group, 
haptens for antibody recognition or biotin for binding PCR products to avidin coated 
wells.
Using both the Phosphite Triester Method to synthesize oligonucleotides as probes and 
PCR to amplify duplex DNA targets, we now have the possibility of creating efficient, 
highly sensitive assays.
2.2.7 Cystic Fibrosis.
ô f
In humans each cell contains 2^chrom osom es and each chromosome is divided into 
genes. The task o f each gene is to make specific protein to firnction in the cells of different 
organs. When a gene is defective, the protein it makes is faulty and as a consequence the 
target organ malfimctions.
The cystic fibrosis (CF) gene has been shown to be on chromosome 7^ “' l  When the CF 
gene is defective, the lungs, pancreas and liver o f the patient are particularly affected. An 
individual has two copies o f chromosome 7 in every cell (except eggs and sperm), one 
inherited fiom each parent. In a few genetic disorders a single defective gene is sufficient
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to cause all the symptoms o f the disease, but not CF, where the defective gene must be 
present on both cliromosomes 7. If the CF gene occurs on one cliromosome and is normal 
on the other then the person is deemed a carrier (or heterozygote) and shows no 
symptoms of the disease. The normal gene compensates fully for the CF gene and because 
of this CF is deemed a recessive disease.
Recessive diseases such as CF are quite rare but the carrier frequency is quite high. CF 
occurs in 1 in 2500 births yet 1 in 25 o f the population are carriers, that equates to around 
2 million carriers in Britain. 1 in every 600 pregnancies has a 25% risk of producing a CF 
cliild. For two carrier parents the possibilities are;
1 A 1 in 4 chance child has CF.
2. A 2 in 4 chance child will be a carrier showing no signs of disease.
3. A 1 in 4 chance child is normal and will not pass CF gene on to friture generations.
2.2.8 The oligonucleotide test system using intercalator/sensitizer (2).
The only way to test the theories and concepts developed during tliis work was to perform 
an actual homogeneous assay. Cellmark Diagnostics kindly provided a probe strand and 
two targets. The assay was to be performed 'blind' in that the matched target was only 
know to Cellmark. The test would be for our assay to detect which target was matched 
and which target was totally unrelated.
The probe was a 24mer i.e 24 base pairs in length and labelled P. The other two targets 
were labelled Q and R.
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2.2.8.1 Preparation o f the probe/EDTA adduct.
5"  3 '
Probe P: HjN-CCH^VO-AA G A T GAT A TT TTC TT T  A&T G G T  G
The 5'-aminohexyl group was reacted at room temperature with a minimum 25 fold excess 
of EDTA dianhydride in lOmM Tris buffer at pH 9.0 for 24hrs. This was followed by the 
addition of a minimum 25 fold excess o f europium (III) chloride to give the chelate 
derivative.
The chelate was purified by passing the whole solution tlirough a Sephadex G25 column 
(NAP 5) using lOmM Tris/HCl at pH 7.5 as the eluent, taking ca. 10-20pl fractions. The 
collected fractions were individually subjected to U.V. analysis at 260mn, with those 
fractions showing strong absorption at 260nm being combined. The presence o f 
tagged europium could be checked with the addition o f a sensitizing molecule such as 
PDCA and irradiation with U.V. light to generate lanthanide luminescence (see next 
section). The final concentration probe in the combined fractions was determined by O.D. 
measurements using a Pharmacia Gene-Quant automated analyzer. The scheme is shown 
in Figure 7.
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Figure 7 Preparation of the Eu.EDTA adduct.
2.2.S.2 Hybridization experiments.
Lovgrei#^^ had developed several hybridization methods for europium labelled 
oligonucleotides and it was decided to follow his procedures initially. 150pl of target 
oligonucleotide to dilute with TRIS/HCl buffer to the concentration o f the probe (1x10'^ 
M). Hybridization of the target with the labelled probe was carried out in a mixture of 
25pi Denhardt's solution^^^  ^(seium albumin, ficoll, polvinylpyrollidine and 18mQ water.) 
and 600pl buffer (O.IM Tween20,0. IM  NaCl, 0. IM  MgClj and lOmM HEPES) at 42°C 
for 3hrs, giving a final concentration of 5xlO'®M for the duplex.
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After hybridization was complete, a solution o f the sensitizer (2) at SxlO'^M from a stock 
solution o f IxlO'^M was made up in Tris/HCl buffer and added to the targets and left to 
equilibrate for Ihr. The luminescence o f each solution was measured after excitation at 
299nm. Following this measurement a series o f serial dilutions were performed on both 
solutions (Q and R) the final concentration being 2.6x10'^M (112x dilution). The results 
are shown in Tab le 1.
Concentration (M) Oligo R  (I,„J Oligo Q (I„, J Ratio R:Q
3.0x10'" 140 60.5 2.3 : 1
1.5x10" 86 39 2 .2 : 1
3.8x10'" 30 15 2 : 1
1.3x10" 9 3 3 ; 1
5.4x10'® 3 0.4 7.5 : 1
2 .6x 10'® 1.12 0.05 22.4 : 1
Tab le 1 Luminescent studies from the hybridization o f probe F with two targets 
R and Q. Excitation Xg^=299nm. EmissionXg^, =615nm.
From these results we concluded that there was a distinct difference in the luminescent 
intensities between R and Q, indicating that R was the matched target and that Q was the 
m ismatched target. R  giving the stronger signal compared to that of Q. On dilution a 
more rapid decrease is seen in Q's intermolecular (background) signal, than for R’s 
coopei ative intramolecular signal. Dilution tends to decrease intermolecular effects and 
as a result the discrimination between the two targets increases significantly.
The structure of both targets were;
Target R  (Matched) TT CTA CTA TAA AAG AAA TTA CCA C
Target Q (Unrelated) G TC CAT TAA CAT CTG TCT TCC ACT AAG G G G
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The readings obtained were a little higher than expected and probably due to excess free 
europium in solution after the NAP-5 column.
2.2.S.3 Testing the hybridization conditions.
Another potential problem was the hybridization conditions. Being chemists and not 
biochemists we had no experience of handling DNA or the conditions required. A test was 
required to establish whether our conditions were promoting duplex DNA formation 
between the probe and matched target.
A characteristic o f intercalation compounds is the change in their luminescence when 
intercalated. We compared the expected behaviour o f the Icnown intercalator etliidium 
bromide (Sigma Aldrich, cat. number using our hybridization conditions, on
probe P and two targets R  and Q and on Calf Thymus DNA (duplex DNA, Sigma Aldrich, 
cat. number D1501). The results are shown in Tab le 2.
Probe P/Target R Probe P/Taiget Q Calf Th)imis DNA None
Uiiliy. 25*C 42“C Unhy. 25°C 42°C Unhy. 25°C 42*C
EUi.B 503 489 299 510 488 490 288 291 280 508
Table 2 Test for duplex DNA(lxlO'^M) using etliidium bromide (IxlO'^M). 
Fluorescence measured at 506nm. The temperature given indicates the 
mixture was heated to that temperature then cooled to room temperature 
(20T;) when the readings were taken. Unhy. indicates the DNA was added 
and not hybridized. None indicates no DNA added.
The considerable fall (approximately 50%) in ethidium fluorescence in both calf thymus 
duplex DNA and our probe P with matched oligonucleotide target R gave us tremendous 
confidence that our hybridization conditions were indeed promoting duplex DNA 
formation.
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2.2.84 Further experiments.
Following the success o f the previous experiment further probe and targets were 
synthesized by Cellmark. Experiments again used sensitizer /intercalator (2), concentration 
( 1 x 1 mol  in 1ml) and the labelling/hybridization conditions previously described on 
page 115. The solutions were serially diluted using TRIS buffer. The assay was performed 
"blind". The results are shown in Tab le 3.
Targets
Probe 3284 3288 3287 2864
Concentration (M) 8xlO'"M 8xlO'"M 8xlO'"M
4.1x10'" 28 15 0.8
8.2x10'^ 9 1.52 0.27
8.2x10-^ 1.12 0.05 0.04
8.2x10'^ 0.2 0.02 0.01
Tab le 3
3284 (Probe) 
Concentration:
Assay with new probe 3284, sensitizer/intercalator (2) at IxlO'^M.
5' 3'
H2N-(CH2)e-0-GAG ATC AAC GAG CAA GAA TTT CTT 
1 .884x10 '%  24mer.
3288 (mutant target) G C T AAA GAA A TT CTT GOT C G T TGA TC T CCA CT
Concentration; 1 .795x10 '%  32mer.
3287 (normal target) G C T AAA GAA A TT CTT G CT C G T TGA C C T CCA
Concentration: 
2638 (unrelated) 
Concentration:
1 .443x10 '%  32mer.
GAT CAT TCA TGA CAT TTT AAA AAT TAG AGG 
1 .544X 10 '%  30mer.
There is a clear distinction between the three oligonucleotide target results. The assay 
results show clear discrimination between matched mutant target (3288) and an unrelated
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sequence (2638). Of greater interest was the discrimination between matched mutant 
target and one base pair mismatched normal target (3287). This difference was also upheld 
on dilution and was still significant approaching x lO '^ ,  3287 and 2368 fading to 
background levels at SxlO’^ M.
23.6.3 Assay using PCR derived products.
The next stage of the assay was to test the G5 SID-mutant specific probe 3284 with some 
longer strands, synthesized by PCR. PCR products are double stranded and must be 
dehybridized by heating above the melting temperature (60°C) for lOmins. Again the assay 
was performed "blind" and used the same conditions as the previous experiments.
GD/GD Exon 11 homozygote, mutant sequence only, 153mer.
GGT AAT AGG ACA TCT CCA AGT TTG CAG AGA A.\G ACA ATA TAG TTC TTG GAG A A G  GTG 
G .\A  TCA CAC TGA GTG GAG ATC AAC GAG C .\A  GAA TTT CTT TAG C .\A  GTG TGA ATA ACT 
AAT TAT TGG TCT AGC A .\G  CAT TTG CTG T.\-V ATG TCA TTC
Concentration; 1. 5x10"*M.
Exl 1+/+ Exon 11 homozygote, normal sequence only, 153mer.
GGT AAT AGG ACA TCT CCA AGT TTG CAG AGA AAG ACA ATA TAG TTC TTG GAG . \A G  GTG 
GAA TCA CAC TGA GTG GAG GTC AAC GAG C AA  GAA TTT CTT TAG CAA GTG TGA ATA ACT 
AAT TAT TGG TCT AGC AAG CAT TTG CTG TAA ATG TCA TTC
Concentration; SxlO'^M.
GD/+ Exon 11 heterozygote, mutant/normal sequences, 153mer. 
Concentration; l.OxlO'^M.
Ex 10+/+ Exon 10 unrelated normal sequence, 221mer.
TTT CAT TCT G Tl CTC AGT TTI TCC TGG ATT ATG CCT GGC ACC ATT AAA G AV. AAT ATC 
ATC TTT GGT GTT TCC TAT GAT GAA TAT AGA TAC AGA AGC GTC ATC AAA GCA TGC CAA 
CTA GAA GAG GTA AGA AAC TAT GTG AAA CTT TTT TGA TTA TGC ATA TGA ACC CTT CAC 
ACT ACC CAA ATT ATA TAT TTG GCT CCA TAT TCA ATC GGT TAG TCT ACA TA
Concentration; SxlO'^M.
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-/- Completely unrelated sequence chosen at random, 153mer.
Concentration; 1.2x1
The initial results can be seen in Table 4
Background GD/GD ExlO+/+ Exl 1+/+ -/- GD/+
Intensity 0.95 38 .5 21.1 18.5 7.1 35
Table 4 Results of probe 3284 (lxlO'"M), PCR products (IxlO'^M) and 
intercalator/sensitizer (2) (lx lO ‘"M),
and Table 5.
Background GD/GD Ex 10+/+ Exll+/+ -/- GD/+
Intensity 0.1 10.3 2.4 2.3 0.9 6.8
Table 5 Results of probe 3284 (IxlO'^M), PCR products (IxlO'^M) and 
intercalator/sensitizer (2) (IxlO'^M).
These results clearly shows that the correct sequence is correctly identified and gives the 
highest reading (GD/GD). Some concern was raised that the completely unrelated 
sequence gave readings with the probe. This can be explained by some adventitious 
binding that can occur between unrelated strands of DNA^^^ .^
Another concern was that the coirect results were always obtained but reproducibility was 
a problem. Overall the assay was successful in all the tests so far but a problem with the 
purity o f the probe was identified. Several new probes were ordered to test their purity 
and to extend the assay, a noimal probe (3848) as opposed to a mutant probe (3849) was 
ordered.
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As discussed with the last series the PCR targets need to be adequately denatured and 
unhybridized. Attempts to follow the dénaturation o f the PCR targets by UV 
measurements, the optical density should increase up to ca. 40% on splitting o f the double 
stranded PCR material, failed since we could not utilize a proper heating system and an 
inadequate buffer system. For example changes in the OD readings o f <10% were 
observed by the time the PCR targets were heated, cooled and the readings taken. Initial 
attempts at conducting dénaturation at 90°C also failed.
Minor changes to the buffer system were also required in order to stabilize readings. 
Originally the NaCl concentration was O.IM and tins was increased to l.OM. Sodium 
concentration is important in order to stabilize the duplex when formed.
Once the probes had been conjugated with EDTA.EiP^, the fractions were monitored by 
UV, the fractions containing material with at 260nm were collected and the final OD 
measurement used to estimate the concentration o f DNA present. A check on purity was 
obtained by measuring the ratio of at 260/240nm; for good DNA material this should 
be 1.8; any lower figure indicates traces o f organic material such as un-deprotected DNA 
(tritylated DNA).
A new set of experiments were performed at lower concentration than attempted before 
and the results can be seen in Table 6. The buffer used in these experiments was the same 
as page 115 except 1 .OM NaCl was used in place of O.IM NaCl.
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Concentration of Targets (M).
1.8x10-^® 9x10" 4.5x10'" 2.25x10'" 1.1x10"
GD/GD 0.64 0.5 0.23 0.13 (0.09)
GD/+ 0.43 0.23 0.12 0.10 (0.08)
+/+ 0.22 0.13 0.06 0.03 (0.015)
Control 0.095 0.05 — —
Calc. GD/+ 0.43 0.315 0.145 0.08 0.05
Table 6 Probe concentration 5.8xlO'®M and sensitizer l.SxlO'^M.
At concentrations o f l.lx lO ‘"M  the readings are very noisy and the instrumental 
responses below 0.2 tend to be non-linear. The readings do tend to vary with time 
(±15%), generally slowly increasing to a maximum after 2hi s. This may be due to the 
intercalator "selecting" the optimum site for intercalation. The relative order of the 
readings stay the same i.e. GD/GD > GD/+ > +/+. The calculated value for GD/+ is based 
on the premise that 0.5(GD/GD - control) + 0.5(+/+ - control) + control = 0.5(GD/GD 
± +/+).
These readings are in the order expected. Again +/+ gives a reading above the control 
suggesting some weaker cooperative effect is occurring with the base mutation at the n-4 
site. The observed figures are within experimental error of these values. The results were 
duplicated by repeating the procedure from the very beginning with fresh samples and 
solutions and similar results obtained indicating that the experiments produce a real effect.
The assay was then to be repeated with a normal probe (3484).
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2.2.8.6 Normal probe compared to mutant probe.
3 849 (mutant probe (M)) NH^-GAG ATC AAC GAG CAA GAA TTT CTT GC.
Concentration: 7.463x10"^M.
3 848 (normal probe (N)) NH^-GAG GTC AAC GAG CAA GAA TTT CTT GC.
Concentration: 5.887x10"%
3482 (3' labelled mutant probe)T GGA ATC AÈA CTG AGT GGA GAT CA-NH^. 
Concentration: 1.385x10'%.
3435 (totally unrelated) CTC TTG  GAT A TT CTC GAC ACA GCA G G T CCT 
Concentration: 1.333x10'%.
3287 (normal target) G CT AAA GAA ATT CTT GCT CGT TGA CCT CCA CT 
Concentration; 1.443xlO'^M, 32mer.
3288 (mutant target) GCT AAA GAA A TT CTT GCT CGT TGA TCT CCA CT 
Concentration; 1.795x10'% , 32mer.
The results of the experiments with the mutant probe (3849) with matched mutant target 
(3288) and normal target (3287) are shown in Table 7.
3288 (M Target) 3287 (N Target) Control
3849 (M Probe) 12.3 9.4 3.64
Tab le 7 Target lx lO '% , Probe lx lO '% , and sensitizer 2x10"%.
The correct sequence is observed but the discrimination between matched and mismatched 
or normal target was not as good as the probe 3284 series).
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The normal probe 3848 was then labelled using the standard procedure and was tested 
with targets 3288 and 3287. The readings were low in both cases and comparable to 
control readings (no target). The results were repeated on several occassions by 2 
different workers and the same results obtained, with no consistency to  them. This 
suggested that either the probe 3484 was not the correct probe or had deteriorated or the 
targets had deteriorated. As shown in Tab le 8.
3288 (M Target) 3287 (N Target) Control
3848 (N Probe) 0.242 0.270 0.154
Table 8 Target lxlO ‘% ,  Probe lx lO '% , and sensitizer 2x10"%.
Ultimately we wanted to repeat the PCR target assays using the normal probe to get a 
complementaiy set of results to the mutant probe results already obtained. We expected 
the strongest signal with the +/+ material followed by GD/+ (which should be the same 
as the mutant target reading) and the GD/GD sample giving the weakest result. Again we 
repeated the assay twice and no meaninghil results were obtained, further evidence that 
the normal probe 3848 was not the correct material.
Following on from this disappointing result we attempted to develop an HPLC system for 
evaluating the probe and target samples and our conjugated derivatives. New probes and 
target were also ordered.
3961 (normal probe (N)) NH^-GAG G TC AAC GAG CAA GAA TTT CTT GC.
Concentration; 2.839x10'% .
3960 (normal target) GCT AAA GAA ATT CTT GCT CGT TGA CCT CCA CT
Concentration; 1.443x10"%, 32mer.
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22.8.1  HPLC purification o f the DNA probes and targets.
The material selected for packing the HPLC columns was Phasesep 'Spherisorb' ODS l,
5micron, a reverse phase column. The initial eluents were acetonitrile (17%) and water 
(83%) mixtures which worked well but in a paper Hill and Mayhew^^"  ^ suggested the 
addition of 0.02M triethylammonium acetate (TEAA) buffer. Also isochratic systems 
proved better than gradient elutions, which tended to increase baseline drift. The results 
can be seen in the A ppendix 1.
The mutant probe 3849 disappeared on conjugation with EDTA, new peaks being formed 
and eluting much quicker than unlabelled probe. The normal probe 3961 however showed 
no new pealcs after attempted conjugation with EDTA. This indicates that the aminohexyl 
group is not present and a problem obviously occurred during the synthesis o f the normal 
oligionucleotide target. Normal probe 3484 was not tested due to lack of sample.
2.3.6.6 Thermal studies.
Several control studies were perfomed at both Brunei and Cellmark (thanks to Dougie 
McKechnie at Cellmark for his assistance).
Samples o f Eu.EDTA and the sensitizer were added to a typical PCR cycle and then 
compared to the results o f a PCR cycle without the addition of these. Electrophoresis 
confirmed that there was no difference between the PCR DNA products. The reagents 
therefore do not interfere with the TAQ enzyme of the reading of the transcription from 
the primers.
The standai d sensitizer and the EDTA mono amide complex of europum. The luminescent 
studies of these compounds (1:1) at ca. 1x10'%  in standard buffer (IM  NaCl, O.IM 
HEPES) were measured before and after heating to 95”C for period of 5rains up to 
30mins. the luminescence did change slightly over this period. Initially the reading was
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increased slightly (20 to 23 units) but after leaving to cool to room temperature for 6hi s 
the intensity readings gradually decreased, dropping even further overnight indicating a 
problem with the stability of the intercalator/sensitizer molecule.
r2.3.6.7 Preparation of the new nomal probe 3922.
A
3922 GAG G TC AAC GAG CAA GAA TTT CTT GC
Concentration: 5.688x10'% .
Earlier attempts to conjugate the normal probes 3848 and 3961 had failed due to the 
impure nature of the sample provided. A new sample o f normal probe 3922 was obtained. 
Once again the material was unpurified and from its OD and HPLC characteristics 
contained a lot of remaining tritylated material and attempts to conjugate the new probe 
3922 with EDTA and europium were also unsuccessful. These problems raised some 
concerns about the robustness of the method used for labelling the oligonucleotide probes 
with EDTA and europium ions.
The conjugation o f the aminohexyl group o f the probe with EDTA dianhydride under 
basic, aqueous conditions looks simple. HPLC and OD measurements of the conjugated 
probes, after purification through NAP-5 columns, showed that the reaction is inefficient 
with yields ranging from 5-15%. Thus with a starting concentration of DNA o f 5x10 '%  
and only about 10% yield, a maximum concentration o f labelled DNA of 5x10 '%  is 
obtained.
Some o f the losses can be explained by the precipitation o f europium oxides during 
conjugation due to the 25 fold excess o f europium chloride added at this stage. This 
precipitation leads to some co-precipitation o f the oligonucleotide and hence the losses 
observed. Further work on the conjugation method is required.
Another problem lay in the low solubility of the EDTA dianhydride in a wide range of
126
Results and Discussion: The
solvents, including water. Improved solubility in water occurred when the EDTA 
dianhydride was predissolved in either N-methylpyrrolidone or acetonitrile and then 
adding this as aliquots to the aqueous solutions o f the buffered DNA.
The probe 3922 (lOOpl, 5.688x10'%) was added to EDTA dianhydride (0.91mg in 50pl 
o f MeCN) at pH 8.5 and the solution stirred vigorously for 12hrs at room temperature. 
Europium (III) chloride hexahydrate (l,563mg in 50pl water) was added and the solution 
stirred for a fiirther 4hrs. A milky suspension formed.
A NAP-5 column was prewashed with 0.02M TRIS buffer (10ml at pH 8.5). The sample 
was eluted with the same buffer and 20pi fractions collected. Initial fractions showed low 
ODs and were discarded, fractions 10-20 showed the correct OD at 260nm. The 
combined fractions were then passed through a second NAP-5 column eluting with the 
same buffer. Again fractions 5-9 showed some OD and were set aside. Fractions 10-15 
were combined as the 260nm peak was strongest. The OD ratios o f260/240 showed the 
later fractions were the purest.
Fractions 10-15 combined;
M.Wt. 7029
Ratio (260/240) 1.757 (1.8 is good)
Purity 97%
Concentration 2 .46x10'%
Fractions 5-9
M.Wt. 7029
Ratio (260/240) 1.43 (1.8 is good)
Purity 79%
Concentration 5.638x10*%.
Because of the concerns with the normal probe 3922 hybridization studies were confined
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to oligonucleotide targets not PCR products. Starting concentration ratios o f 1:1:1 for the 
probe 3922, intercalator and targets were used (2x10*%). The medium for hybridization 
was as described earlier on page 121. The solution was heated to 95°C for 5mins, during 
which the solution appeared cloudy, before rapid cooling to 0°C in an ice/salt bath, the 
solution cleared. The solution was then heated to 42-45°C for 10-15mins and allowed to 
cool back slowly to room temperature. The solutions were allowed to equilibrated for Ihr 
prior to readings being taken. The results are shown in Tab le 9.
3288 (M Target) 3860 (N Target) Control
3922 (N Probe) 3.82 2.64 0.575
64x Dilution 0.168 0.110
Table 9 All initial concentrations are at 2x10*%. See page 118 for structures.
The readings are in the expected order and they hold up on 64x dilution at which the 
background control is unobservable.
2.2.9.1 Water based versus triethylamine based labelling systems.
Parallel experiments were conducted with triethylamine and water.
To lOOpl o f probe and lOOpl o f pure water was added 5pi triethylamiiie/water 
accordingly. EDTA anhydride (25fold excess) was added portionwise over 2hrs. The 
reactions were stirred for 8hrs and then europium (III) chloride hexahydrate (25 fold 
excess) was added and the reaction was stirred for a further Ihr. The reaction products 
were then purified in the usual way NAP-5 columns etc.
a) Triethylamine reaction labelled 3961fN probe).
M.Wt.= 7029 Purity= 99% Ratio 260/240= 1.793
Concentration 6.97xlO*"M.
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b) Water reaction labelled 3961 fN probe).
M.Wt.= 7029 Purity 96% Ratio260/240= 1.79
Concentration 1.69x10’% .
The probe was hybridized under the normal conditions and the final concentration o f all 
components target, probe and sensitizer (2x10'% ). control experiments were conducted 
with the equivalent volume of buffer rather than any target DNA. The results are shown 
in Tab le 10.
3860 (N Target) 3288 (M Target) Control
EtjN 3961 2.66 0.77 0.65
Water 3961 2.36 0,94 0.74
Tab le 10 Results o f the normal probe 3961.
The use of triethylamine did not affect the reaction in any way. However it did speed up 
the conjugation between the EDTA and the probe.
The next experiment was to test the normal probe 3961 with the PCR targets.
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Hybridization o f normal probe 3961 with PCR products.
The probe was hybridized with the PCR products using the normal protocol previously 
described, the concentration o f the components were as follows;
Probe 1x10'"M Targets 1x10'% Sensitizer lxlO'"M 
The results are shown in Tab le XI.
GD/GD GD/+ +/+ Control
Et^N 3961 0.29 0.43 0.35 0.15
Water 3961 0.94 1.26 1.71 0.34
Table 11 Normal probe 3961 results.
A new supplier of DNA probes and targets was found (Oswel DNA service). We also 
synthesized a new, more robust intercalator/sensitizer.
2.3 Oligonucleotide test system using the second intercalator/sensitizer molecule.
The amide link used to connect the sensitizer to the intercalator in the first 
intercalator/sensitizer molecule (2) had concerned us from the outset. Specifically, a white 
precipitate formed when a solution of the probes was left for several days. This precipitate 
was too fine to isolate and could not be identified. However the amide linlced molecule 
showed a degeneration in its ability to sensitize europium over a period o f days. The 
conclusion was that the amide link was hydrolysing in the conditions used for storing the 
stock solution.
Thus a more robust linker was require which led to the synthesis of the second sensitizer 
(34), with an all carbon linker group.
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m
N —
OH HOHOOH
(34)(2)
Figure 8 The two sensitizer/intercalator molecules.
A new company Oswel DNA Seiwice based in the University of Southampton synthesized 
a set o f oligonucleotides;
M3560 TG C TAA AGA AAT T C T  TG C  T C G  TT G  ATC T C C  A CT
Mutant Target 33mer 2.34xlO'‘*M.
M3561 TGC TAA AGA AAT TC T TG C TC G  T T G  ACC TCC ACT
Normal Target 33mer 2.23xlO”^ M.
M3562 NHr(CH2)6-0-GAG ATC AAC GAG CAA GAA TT T  C TG  C
Mutant Probe (n-4) 25mer 2.49x1 C'^M.
M3S63 NH2-(CH2)rO.
Normal Probe 25mer
G TC AAC G A G  CAA GAA TT T  C T G  C 
1.63xlO'^M.
M3564 NHr(CH2)6-0-AGA TCA ACG AGC AAG AAT TTC TGC
Mutant Probe (n-3) 24mer 1 68xlO"^M.
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M3 565 NH2-(CH2)6-0-GAT CAA CGA GCA AGA ATT TC T GC
Mutant Probe (n-2) 23mer 2.211xlO“^ M.
M3 566 NH2-(CH2)6-0-GGA G A T CAA CGA GCA AGA ATT T C T  GC
Mutant Probe (n-5) 26mer 2,14x10"^M.
The new intercalator/sensitizer molecule is quite insoluble in water and a small amount o f 
DMSO was required for dissolution in water.
(n-x) refers to the position o f the mutant site distance from the aminohexyl group at the 
5‘ end of the oligonucleotide probe.
The probe oligonucleotides were labelled as previously described and the hybridisation 
conditions were also unchanged. The results are shown in Table 12.
Probe N  Target 3561 M Target 3560 Background
3565 u-2 6.00 3.67 0.186
3564 u-3 1.49 3.87 0.186
3562 n-4 3.2 5.3 0.22
3566 u-5 4.97 2.40 0.186
3563 Nomial 4,96 2.54 0.186
Tab le 12 All components are at IxlO'^M (Target, probe, sensitizer).
Excitation at 320nm. readings taken at X^^ 615nm.
The above table shows some discrimination between match and mismatch DNA targets^^^l 
A further experiment was performed to test the effect o f temperature on the assay. 
Obviously the temperature cannot be greater than the melting temperature o f the DNA 
(42°C), The effects are shown in Tab le 13.
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Temp. “C Mutant Target 3560 Noiiual Target 3561
3562 M 3563 N Ratio 3562 M 3563 N Ratio
22 26.5 (0,69) 12.0 (0.69) 2.3:1 12.0(0.69) 18.7 (0.69) 1:1.6
32 14.0 (0.43) 3.05 (0.43) 5.2:1 2.3 (0.43) 8.3 (0.43) 1:4.2
Table 13 The effect of temperature on the assay. Components target IxlO'^M and 
probe/sensitizer at 5 x 1 0 '^ . The readings in brackets are the background,
At ambient temperatures 21-22°C only modest discriminations were observed, the match 
and mismatch sets giving ratios of ca. 2 : 1 . the results were reproducible and gave the 
appropriate crossover results i.e. both mutant and normal probes gave higher readings 
with the matching target than with mismatching target. The discrimination was sensitive 
to temperatures.
The results indicate one o f the first methods for the direct in situ identification of point 
mutations in a target strand of DNA.
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3.1 General.
The following abbreviations have been used in this experimental section; AcOH (acetic 
acid), AICI3  (aluminium chloride), CDCI3  (deuterated chloroform), CHCI3  (chloroform), 
CCI4  (carbon tetracliloride), DCM (dichloromethane), DMSO (dimethyl sulfoxide), 
DMSO-c^ (deuterated dimethyl sulfoxide), D^O (deuterated water), EDTA 
(ethylenediaminetetraacetic acid), EtOH (ethanol), HCl (hydrochloric acid), HEPES (N- 
(2-hydroxyethyl)piperazine-N-ethane sulfonic acid, HNO 3  (nitric acid), pet. ether (petrol 
ether), H 2 SO4  (sulfuric acid), K 2 CO3 (potassium carbonate), MgSO^ (magnesium sulfate), 
MeCN (acetonitrile), MeOH (methanol), NaCl (sodium chloride), Na2 C0 3  (sodium 
carbonate), NaHC 0 3  (sodium hydrogen carbonate), Na2 S0 4  (sodium sulfate), THF 
(tetrahydrofuran), TRIS (2-amino-2-(hydroxymethyl)-1,3-propanediol and TWEEN 
(polyoxyethylenesorbitan monolaurate).
Purifications by chromatography were conducted using Kieselgel 60 silicagel or Brockman 
Grade I neutral alumina, with redistilled solvents. Thin layer chromatography (t.l.c.) was 
performed on either Whatman 2,5cm x 7.5cm glass backed plates with 0.25mm layer of 
silica gel 60 F2 5 4 , or on Merck E-type aluminium backed sheets with 0.2mm layer of 
aluminium oxide 60 F 2 5 4  (neutral).
Melting points were determined on a Reichert-Jung Thermovar hot-stage microscope 
melting point apparatus and are uncorrected. Abbreviation dec. means decomposed.
Microanalyses were performed by MED AC Ltd., Bmnel University on a Carlo Erba 1106 
elemental analyzer (dynamic combustion system) or on a Control Equipment Corporation 
Model 240 XA (static combustion system).
^H-nmr spectra were recorded on a Varian CFT-20 (90MHz) or a Bruker AM360 
(360MHz) spectrometers. Resonances are reported (frequency; solvent); ô -  shift in ppm 
from tetramethylsilane (internal reference) at Oppm and the multiplicity of signals as; s
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(singlet), d (doublet), dd (double doublet), q (quartet), t (triplet), m (multiplet); br. 
(broad); J  values are in Hz.
Mass spectra were obtained on an A EIM S902 spectrometer or at the ESPRC facilities. 
Department o f Chemistry, University College, Swansea, Wales for fast atom 
bombardment (FAB) and accurate mass measurements.
Infra red spectra (i.r.) were obtained on a Perkin Elmer 1420 ratio recording 
spectrophotometer as potassium bromide (KBr) discs unless otherwise stated.
3.2 Luminescence measurements.
Phosphorescence; excitation and emission were recorded on a Perkin Elmer LS50B 
luminescence spectrometer at room temperature, using either a 2 ml or 800pl quartz cells 
and the following parameters;
Excitation spectra; Slit width lO.Onm : Gate time 1.0ms
Emission spectra; Slit width lO.Onm ; Gate time 1.0ms : Delay time 0.1ms
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2.9-Bisftrichlnromethvl)-1.10-phetianthroline (4).
Neocuproin hemihydrate (3) (5,43g, 25mmol) was dissolved in CHCI3 (25ml) and CCI4  
(150ml). N-chlorosuccinimide (18.7, 140mmol) and a catalytic amount o f 3- 
chloroperoxybenzoic acid (MCPBA) was added and the mixture was heated at reflux for 
16hrs. On completion the reaction mixture was washed with 10% Na 2 C 0 3  (aq.), dried, 
filtered and evaporated. The crude residues were purified by elution through a silica plug 
(2:1 DCM:40-60 pet. ether.) and crystallization from CHClg/EtOH to give the title 
hexachloride (4) as colourless crystals (9.88g 95% yield); m.p. 212-214°C (lit. 212- 
214T); ÔH (90MHz, DMSOnü^ 8.84 (2H, d, J 8 .6 ), 8.48 (2H, d, J 8 .6 ), 8.26 (2H,s); m/e 
412 (MT), 377 (M-Cl), 342 (M-2C1).
1.10-Phenanthroline-2.9-dicarboxylic acid HV
(4) (2.07g, 5mmol) was mixed with 98% H 2 SO4  (6 ml) and heated to 90“C for 3hrs, then 
cooled, diluted with water (10ml) and heated for a further 30mins. The mixture was then 
poured into water and the solid collected, washed with water and dried. The crude solid 
was recrystallized from THF to give the title diacid (1) as a wliite microcrystalline solid 
(1.41g, 99% yield); m.p. >230°C dec. (lit. 238°C dec ); (Found: C, 58.55; H, 3.46; N, 
9.82%. C 14H 8N 2 O4 .H2O requires: C, 58.75; H, 3.52; N, 9.79%.); v^cm"^ 3400 (COOH), 
1720 (C=0), 1230 (C-0), 870 (OH); 0» (90MHz, DMSO-c/g) 8.73 (2H, d, J8 .3 ) , 8.41 
(2 H, d, y  8.3), 8.35 (2 H, s), 4-5 (4H, br. D 2 O ex.); m/e 224 (M^-COJ, 180 (M-2 CO 2 ).
2.9~Bisfmethoxycarhonyl)-L 10-phenanthroline (5).
(4) (0.4Ig Immol) was mixed with 98% H 2 SO4  (5ml) and heated to 90°C for 3 hrs. The 
solution was cooled and MeOH (10ml) was added carefully, then heated at reflux for a 
further 30mins.The solution was poured over ice and the precipitate collected, washed 
with water and dried. The crude solid was recrystallized from CHCl3 /MeOH to give the 
title dimethyl ester (5) as a white solid (0.26g, 85% yield); m.p. 227-229°C (lit. 213- 
214°C); (Found C, 61.11; H, 4.40; N, 8.84%. C 1A 2N 2 O 4 .H2 O requires: C, 61.14; H, 
4.49; N, 8.91%.); v ^ c m  ' 3450 (H 2 O), 1735 (C=0), 1290 (C-0), 1020 (O-CH 3 ); ô» 
(90MHz, CDCI3) 8.47 (2H, d, J  8.2), 8.35 (2H, d, J 8.2), 7.91 (2H, s), 4.11 (6 H, s); m/e
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296 (M+X 265 (M-CH3O), 237 (M-CO2CH3), 178 (M-2 CO2 CH3 ).
5-Nitro-2.9-dimethvl-l. 10-phenanthroIme (6 ).
Neocuproin hemihydrate (6 ) (lOg, 46mmol) was dissolved in cold fuming H 2 SO4  (45ml) 
at 0 °C, then fuming HNO 3  (50ml) was added carefully and the solution heated to 140°C 
for Ihr. The mixture was then cooled and poured carefully over caished ice, then 
neutralized to pH 6  with solid NajCOa. The precipitate was collected and purified by 
reprecipitation from 2M H 2 SO4  solution with lOmmoI NaOH (aq.), to give the nitro 
compound (6 ) (6 .6 g, 50% yield); m.p. 174°C dec.; (Found C, 64.05; H, 4.83; N, 15.68%. 
C14H 11N 3 O2 .O.5 H 2 O requires: C, 64.12; H, 4.61; N, 16.01%. ); v ^ cm "' 3500-2900 (OH), 
1520 (ArNOj, 1350 (ArNOz); ô » (90MHz, CDCI3) 8.87 (IH , d, J8 .7 )  8.55 (IH , s), 8.20 
(IH, d, J8 .3), 7.62 (IH, d ,J8 .7 ), 7.58 (IH , d ,J8 .3 ), 2.98 (3H, s), 2.97 (3H, s); m/e 253 
(M l, 223 (M-NO), 207 (M-NO 2 ).
2.9-Dimethvl-l. lO-phenanthroline-5.6-diom (7).
The combined aqueous filtrates from the nitration reaction were then extracted with 
C H C I 3  and evaporated to give the crude diotie (7 ) as a by product o f the nitration 
reaction. The crude product was purified by chromatography (silica gel; 2% M e O H  in 
C H C I 3 )  to give the dione (1 ) as a bright yellow solid (0.9g, 16% yield); m.p. 185-186°C; 
v^^cm"' 1690 ( C = 0) ,  1140 ( C - C O - C ) ;  ôy (360MHz, C D C I 3 )  8.38 (2H, d, J8 .2 ), 7.43 
(2H, d, J8 .2 ), 2.83 (6 H, s); m/e 238 (M l, 210 ( M - C O ) .
5-Nitro-2.9-bis-(ttichloromethvl)-phenanthrolme (9).
Crude (6 ) (5.06g, 20mmol) was reacted under the standard perchlorination method as in 
the synthesis o f (4). The crude mixture was purified by elution through a silica plug (2 :1 
DCM:40-60 pet. ether.) and crystallization from CHClg/EtOH to give the title 
hexachloride (9) as lime coloured crystals (7.08g, 75% yield); m.p. 229-23 TC ; (Found 
C, 36.40; H, 1.11; N, 9.13; Cl, 46.51%. C 1 4 H 5N 3 O 2 CI6  requires: C, 36.56; H, 1.10; N, 
9.14; Cl, 46.25%.); v ^cm "' 1340 (NOg), 820-740 (Cl); 0^ (90MHz, CDCI3 ) 9.20 (IH , 
d, J  9.2), 8.79 (IH , s), 8.59 (IH , s), 8.42 (IH , d, J  9.2), 8.39 (IH , d, J  8.7); m/e 459
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(M l ,  424 (M-Cl), 389 (M-2C1).
5-Nitro-2.9-bisfmethoxycarbonyl)-J. 10-phenanthroline H 01
(9) (2g, 4.35mmol) was reacted under the standard estérification method as for (5). 
Recrystallization from CHClj/MeOH gave the title dimethyl ester (10) as white crystals 
(1.26g, 80% yield); m.p 258“C dec.; (Found: C, 55.95; H, 3.22; N, 12.01%.
requires C, 56.31; H, 3.25; N, 12.31%.); v^cm "^ 3500-3200 (OH), 1730 (C=0), 1540 
(ArNOl, 1210 (C-0); 0h(90M Hz, CDCI3 ) 9.15 (IH , d, J 8 .8 ), 8.76 (IH , s), 8.59 (IH , 
d, J 8 .8 ), 8.57 (2H, s), 4.13 (6 H, s); m/e 341 (M l, 311 (M-NO), 283 (M-CO 2 CH3 ), 225 
(M-2 CO2 CH3 ).
5-Amino-‘2.9-bis(methoxycarboml)-L10-phenanthrolirie ( 1 1 ),
(10) (Ig, 3mmol) was dissolved in hot MeOH (100ml) and cyclohexene (1.4g, 17mmol). 
10% Pd-C (0.2g) was then added and heated at reflux for 8 hrs. The mixture was filtered 
through Celite and the solvent evaporated. Flash chromatography (silica; 1 0 % 
MeOH/CHCy gave the title amine (11) as a bright yellow solid (0.71g, ?5%  yield); m.p 
240T  dec..(Found: C, 61.84; H, 4.23;N, 13.18%. C 1 6H 13N 3 O4 requires C, 61.73; H, 4.21; 
N, 13.49%.); v^cm-^ 3350+3250 (N H j, 1730 (C =0), 1280 (C-0); 0» (90MHz, CDCI3 )
8.90 (IH, d, J 8 .8 ), 8.33 (IH , d, J 8 .8 ), 8.15 (2H, s), 6.97 (IH , s), 6,7 (2H, s, D^O ex.), 
3.98 (3H, s), 3.93 (3H, s); m/e 311 (M+), 253 (M-CO^CHg), 195 (M-2 CO2 CH3 ).
5-f6'-Bromohexanamido)"2.9-bis{methoxycarbonyl)-L 10-phenanthroline) (12).
(10) (0.5g, 1.6mmol) was dissolved in CHCI3  (30ml), diisopropylethylamine(0.5g) and 6 - 
bromohexanoyl chloride (425mg, 2mmol) was added dropwise. After stirring for Ihr, the 
solution was washed with 5% NaHCOg (aq.), water and brine. The organic layer was 
dried, filtered and evaporated to give the crude product. Flash chromatography (silica; 5% 
MeOH in CHCI3 ) left a red/brown oil, which was triturated with ether to give the title 
amide (12) as a mustard solid (610mg, 80% yield); m.p. 129-13 rC . (Found: C, 51.94; H, 
4.64; N, 8.22, Br, 15.91%. C^AzNaOgBr HzO requires C, 52.19; H, 4.77; N, 8.30, Br 
15.78% ); v,^,cm-‘ 3460 (NH^), 1750 (C=0 ester), 1720 (C=0 amide), 1560 (NH), 1280
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(C -0); ÔH (360MHz, CDCI3 ) 9.59 (IH , D^O ex.), 8.31 (IH , d, J8 .54 ), 8.29 (IH , d, J  
8.54), 8 . 1 0  (IH , d, J8.55), 7.97 (IH , s), 7.79 (IH , d, 78 .54), 4.13 (3H, s), 4.08 (3H, s), 
3.48 (2H, t, 7 6 .7 ), 2.68 (2H, t, 7 7 .3 ), 2.05-1.55 (6 H, m); m/e 488 (MH+).
5-(6'-(N-Phenanthridmium)-hexafiamido)-2. Ç-bisfmethoxycarbonyD-L 10-phenanthroline 
bromide (13).
Phenanthridine (520mg, 2.9mmol) was melted at 120°C under nitrogen, (12) (525mg, 
1.05mmol) was added over a period o f 15mins and heated at 120°C for 3hrs. After 3hrs., 
the mixture was cooled and dissolved in CHCI3  (lOmls) and dripped into stirring ether 
(100ml). The precipitate was collected and washed with further portions o f ether, then 
reprecipitated as before. The crude precipitate was recrystalized from hot water to gave 
the title dimethyl ester (13) (677mg, 95% yield); m.p. 160°C; (Found: C, 61.14; H, 4.66; 
N, 8.23; M-Br 587.2298. C3 5 H 3 iN 4 0 5 Br.H 2 0  requires C, 61.32; H, 4.85; N, 8.17; M-Br 
587.2294); v ^ cm '^  3500 (NH, OH), 1740 (C =0 ester), 1630 (C =0 amide); 0» 
(360MHz, CDCI3 , poor resolution) 11.42 (IH , s), 10.4 (IH , br. s, D^O ex.), 9.35-7.4 
(13H, m), 5.2 (2H, t), 4.01 (6 H, s), 3.31 (2H, br. s), 2.9 (2H, m), 2.55-1.63 ( 6 H, m); m/e 
587 (M-Br), 529 (M-CO 2 CH 3 ).
5-{6'-(N-Phe7ianthridinium)-hexanamido)-l. lO-phenanthroline-2.9-dicarboxylic acid 
bromide (2 ).
(13) (lOOmg, 0.15mmol) was mixed with water (5ml), AcOH (1ml) and 49% HBr (1 
drop) and heated at reflux for 20hrs. The solution was then decanted from the oily residue 
and freeze dried to give the title diacid  (2) as an orange coloured solid. Purification and 
subsequent analysis of the compound proved very difficult; m.p. 173“C dec.; (Found M-Br 
559.1973. C3 3 H 2 7 N 4 O 5 requires M-Br 559.1981.); (360MHz, DMSO-d^, poor
resolution) 10.47 (IH, s), 10.22 (IH , br. s, D 2 O ex.), 8,03-9.19 (13H, m), 5.18 (2H, m),
4.01 (2H, m), 2.24 (2H, m), 1.62-2.18 (4H, m); m/e 559 (M-Br).
4.7-Diphenyl-2.9-bis(trichloromethyl)-l. 10-phenanthrolme (15).
Bathocuproin (14) (2.5g, 7mmol) was reacted under the standard perchlorination method.
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The crude mixture was purified by elution through a silica plug (2:1 DCM:40-60 pet. 
ether.) and crystallization from CHClj/EtOH to give the title hexachloride (15) as white 
crystals (4.3g, 75% yield); m.p. 278-279°C (lit.268-273“C crude); (Found C, 55.89; H, 
2.46; N, 4.81; Cl, 37.70%. C z A ^ N flg  requires: C, 56.06; H, 2.49; N, 4.94; Cl, 
37.70%.); v„^cm-' 900-700 (C-Cl); 0h(360MHz, CDCI3) 8.22 (2H, s), 7.93 (2 H, s), 7.52 
(lOH, s); m/e 564 (M+), 529 (M-Cl), 494 (M-2C1).
4.7-Diphenyl-L lO-phenanthroline-2.9-dicarboxylic acid (16).
(15) (0,57g, Immol) was heated in 97% formic acid (10ml) for 24hrs. Water (1ml) was 
then added and reflux continued for a further 6 hrs. The solution was then poured into 
water and the precipitate collected. The crude compound was recrystallized from formic 
acid/water giving the title diacid (16) as white crystals (0.38g, 87% yield); m.p. 206“C 
dec. (lit 204-210T dec.); (Found C, 71.44; H, 3.97; N, 6.25%. requires:
C, 71.56; H, 3.70; N, 6.42%.); v^^,cm"^ 3500-3300 (COOH), 1730 (C=0), 1300 (C-0), 
790+720 (Ph); Ôh (360MHz, DMS0-7g) 8.28 (2H, s), 8.01 (2H, s), 7.63 (10H,s), 3-5 
(2H, br. s, D 2 O ex.); m/e 332 (M-2 CO 2 ).
4 .7-Bis('nitrophenvl)-2.9-dimethvl-LlO-phenatithroline (17).
Bathocuproin (19) (360mg, Immol) was dissolved in 98% H 2 SO4  (4ml) at 0°C. 70% 
HNO3 ( 1 ml) was added and the solution was stirred for 2 0 min and then poured over ice. 
The mixture was neutralized with 30% NaOH (aq.) and extracted with CHCI3. The 
organic extracts were dried, filtered and evaporated to give the title dinitro compound
(17) (422mg, 94%). This product was used directly in the synthesis of the hexachloride
(18).
4.7-Bis('nitrophenyl)-2.9-bisftrichloromethyl)-1.10-phenanthroline (18).
(17) (320mg, 0.7mmol) was chlorinated using N-chlorosuccinimide (Ig, 7.5mmol) in the 
standard reaction. Flash chromatography (silica; 60% DCM:40% 40-60°C pet. ether) gave 
the ûtÏQ nitrohexachloride (18) (0.43g, 93% yield); (Found C, 47.36; H, 1.86; N, 8.53%. 
C2 A 2 N4 O4 CI6 requires: C, 47.52; H, 1.84; N, 8.53%.); v^cm '^  1535+1355 (NO,), 850-
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750 (C-Cl); m/e 654 (M+), 619 (M-Cl), 584 (M-2C1).
4.7-Bis(nitt'ophenyl)-2.9-his(methoxycarbonyl)-l. 10-phe?ianthroline (19).
(18) (2g, 3mmol) was reacted using the same method as for (5) to give the title dimethyl 
ester (1.2g, 74% yield); (Found C, 62.12; H, 3.32; N, 10.29%. CggHigN^Og requires: C, 
62.45; H, 3.37;N, 10.40%.); v^cm '^  1725 (C=0), 1530+1350 (NO^), 1260 (C-0); m/e 
480 (M-CO 2 CH3 ), 450 (M-C02CH3-N0),422 (M-2 CO2 CH3 ).
4 .7-Bis(ami7iophenyl)-2.9~bis('methoxycarbonyl)-l. 10-phemnthroIine (20).
(19) (270mg, O.Smmol) using the same method as for (6 ) to give the title diamine (20) 
(170mg, 70% yield) after flash chromatography (silica; 5% MeOH in CHCI3 ); v^ a^xCm'^  
3350-3200 (NH2 ), 1725 (C=0), 1260 (C -0); m/e 478 (M^), 420 (M-CO2 CH 3 ), 362 (M- 
2CO2CH3).
Crotonyl chloride (23).
Crotonic acid (60g, 0.7mol) was heated under reflux with thionyl chloride ( 1 0 0 ml, 
1.4mol) for 2hrs. The mixture was fractionally distilled and the fraction boiling between 
117-124°C (lit. 124-5®C) was collected. The crude fraction was then distilled from 
quinoline (2g) to give the title acid chloride (23) as a clear liquid (61g, 84%yield).
l-Phenyl-2-biiten-l-one (21).
Anhydrous AICI3  (36.7g, 0.275mol) was slurried in benzene (100ml) and cooled to 10°C. 
Crotonyl chloride (26. Ig, 0.25mol) was added slowly over 15mins; a yellow colour 
formed as the AICI3  dissolved and the mixture suddenly solidified. The "solid" was then 
quenched in ice, stirred and extracted with ether. The ether extracts were dried, filtered 
and evaporated giving a yellow oil. Column chromatography (silica; 30%DCM/40-60"C 
pet. ether) gave the crude title ketone (21) as a pale yellow oil. The crude compound was 
then vacuum distilled to give pure (21) (30g, 82% yield); (Found C, 81.84; H, 6.90%. 
CjoHioO requires: C, 82.17; H, 6.89%.); v ^ cm " ' (liquid film) 3080 (Ar.CH), 1680 
(C=0), 1630 (C=C), 770,700 (Ph-); Ôh (360MHz, CDCI3 ) 7.95-7.90 (2H, m), 7.60-7.41
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(3H, m), 7.1 (IH, dq,715.2+1.4), 6.9 (IH , dq, 715.2+1.4), 2.0 (3H, dd, 76.4+1.4); m/e 
146 (M+), 131 (M-Me), 105 (M-CH-CH-Me), 69 (M-Ph).
2-Methyl-8-aminoqiiinoUne (25).
2-Methyl-8-m troquinoline (24) (5.65g, 30mmol) was dissolved in MeOH (70ml) and 
cyclohexene (10ml) and heated. 10% Pd-C (0.5g) was then added and the reaction 
m ixture heated under argon at reflux for 16hrs. The cooled solution was then filtered 
through Celite and evaporated to give the crude product as a yellow/brown solid. The title 
amine (25) was obtained after recrystallization from 60-80 pet.ether (4.41g, 93% yield); 
m.p. 56-57T  (lit. 56°C); (Found C, 75.89; H, 6.31; N, 17.72%. requires: C,
75.92; H, 6.37; N, 17.71%.); v ^ cm '^  3400+3350 (NHg); ô» (90MHz, CDCI3 ) 8.0-6.8 
(5H, m), 4.5 (2H, br. s, D^O ex.), 2.69 (3H, s); m/e 158 (M").
4-Phenyl-2.9-dimethyl-l. 10-phenanthroline (26).
Aminoquinoline (25) (0.79g, 5mmol), ketone (21) (2.19g, 15mmol) and KH 2 ASO4  (Ig, 
5.5mmol) were mixed with c. HCl (40ml) and heated to 80"C for 7hrs. The reaction 
mixture was then basified to pH 10 with 40% NaOH (aq.) and extracted with CHCI3 . The 
organic extracts were dried, filtered and evaporated to leave a brown oil. Column 
chromatography (silica; 2:1 DCM:40-60 pet. ether then 10% MeOH in CHCI3 ), followed 
by cold crystallization from CHCyether gave the crude product. The pure phenanthroline 
(26) was recrystallized from benzene as yellow crystals (0.9g, 63% yield); m.p. 203- 
205°C; (Found C, 84.64; H, 5.67; N, 9.63%. C2 A 6N 2  requires: C, 84.48; H, 5.67; N, 
9.85%.); ÔH (360MHz, CDCI3 ) 8.09 (IH , d, 78 .3), 7.80 (IH , d, 79 .0), 7.61 (IH , d, 7
9.0), 7.52 (5H, s), 7.49 (IH , d, 78 .3 ), 2.98 (3H, s), 2.97 (3H, s) ; m/e 284 (M+).
4-Phenyl-2.9-bisfti'ichloromethyl)-L 10-phenanthrolijie (27).
(26) (0.5g, 1.75mmol) was reacted under the standard chlorination method, 
recrystallization from CHCl3/EtOH to give the title hexachloride (0.75g, 87% yield); m.p. 
218-220T ; (Found C, 48.79; H, 2.06; N, 5.45; Cl, 43.36%. C2 0 H 1 0N 2 CI6  requires: C, 
48.92; H, 2.05; N, 5.75; Cl, 43.32%.); v^cm '^  850-750 (C-Cl); ô» (200MHz, CDCI3 )
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8.43 (IH, d, 78.79), 8.32 (IH , d, 7  8.79), 8.3 (IH , s), 8.05 (IH , d, 79.28), 7.88 (IH , d, 
79.28); m/e 488 (M+), 453 (M-Cl), 420 (M-2C1).
4-Phenvl-l. 10-phetia?ithrolnie-2.9-dicarboxvlic acid (28).
From (2f) using the standard conditions (H2 SO4 /H 2 O) to give the title diacid (28) (81% 
yield); m.p. 215T  dec.; v ^ cm '^  3400-2800 (COOH), 1720 (C=0), 1260 (C -0); 0^ 
(360MHz, DMS0-7g) 8.73 (IH , d, 7  8.3), 8.42 (IH , d, 7  8.3), 8.3 (IH , s), 8.17 (IH , d,
79 .0), 8 . 0 0  (IH, d, 79.0), 7.65 (5H, s), 3-4 (2H, D 2 O ex.); m/e 256 (M-2 CO 2 ).
4-(Nitrophenvl)~2.9-dimethyl-1.10-phenanthroline (29).
(26) (0.5g, 1.75mmol) was dissolved in 98% H 2 SO4  (4ml) at 0"C. 70% HNO 3  (1ml) in 
98% H 2 SO4  (1ml) was added dropwise, keeping the reaction temperature below 15®C. 
After stirring for an extra 20mins, the mixture was poured over ice, neutralized with 40% 
NaOH (aq.) and extracted with CHCI3 . The organic extracts were dried, filtered and 
evaporated to give the title ititrophenyl compound (29) as a beige solid (0.58g, 100% 
yield). The compound was chlorinated directly without purification; m/e 329 (M^), 283 
(M-NO 2 ).
4-(Nitr'ophenvl)-2.9-bis(trichloromethyl) -1.10-phenanthroline T3 01 
From (29) (0.33g, Immol), using N-chlorosuccinimide in the standard perchlorination 
reaction gave the title/?ex-ac/7/or/‘cfe(30) (0.48g, 91% yield); (Found C, 44.82; H, 1.67; N, 
7.58; Cl, 39.66%. C2 0 H 9N 3 O2 CI6  requires: C, 44.81; H, 1.69; N, 7.84; Cl, 39.68% ); 
v^cm '^  1530+1350(N02), 850-750 (C-Cl); m/e 533 (M+), 498 (M-Cl), 463 (M-2C1).
4-(Nitrophenyl)-2.9-bis {'methoxvcarbonyl)-l. 10-phenantrhroline (31).
From (30) (Ig, 1.87mmol), using H 2 SO4  and MeOH in the standard reaction, to give the 
title dimethyl ester (31) (0.6g, 77% yield); (Found C, 63.18; H, 3.57; N, 10.03%. 
C2 2 H15N 3O6 requires: C, 63.31; H, 3.62; N, 10.07% ); v^cm '^  1730 (C =0), 1530+1350 
(NO 2 ), 1260 (C-0); m/e 417 (M+), 387 (M-NO), 359 (M-CO2CH3), 329 (M-CO 2 CH3 - 
NO), 301 (M-2 CO2 CH3 ).
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4 (Aminophenyl)-2.9-fmethoxvcarhonyl)-L 10-phemnthroIine (32).
(31) (Ig , 2.4mmol) was slurried in MeOH (80ml) and ammonium formate (0.76g, 
1 2 mmol) and 10% Pd-C (0.2g) was added. After stirring for 6 hrs, the mixture was filtered 
through Celite and evaporated. The residue was partitioned between CHCI3  and H 2 O; the 
organic solution was then dried, filtered and evaporated. Flash chromatography (silica; 4% 
MeOH in CHCI3) gave the title amine (32) (0.84g, 91% yield); (Found C, 65.18; H, 4.67; 
N , 10.30%. C 2 2 H 1 7N 3 O4 .H2 O requires: C, 65.18; H, 4.72; N, 10.36%.); v^cm '^  
3340+3200 (N H j, 1720 (C =0), 1270 (C-0); m/e 387 (M+), 329 (M-CO2 CH3 ), 271 (M- 
2CO2CH3).
4-(Acetamidophe7ivl)~2.9~bisfmethoxycarbonyl)-L 10-phenanthroline (31).
(38) (194mg, 0.48mmol) was dissolved in CHCI3  (15ml) and diisopropylethylamine 
(130mg, Immol). Acetyl chloride (200mg) was then added and the mixture stirred for Ihr, 
then washed with 5% NaHCOg (aq ), water and brine, dried, filtered and evaporated. Flash 
chromatography (silica; 1 0 % M eO H /CH Cy gave the title acetamide (31) as the 
hem ihydrate (190mg, 91% yield); (Found C, 66.02, H, 4.45; N, 9.55%. 
C2 A 9 N3 O 5 .O.5 H 2 O requires: C, 65.74; H, 4.60; N, 9.58% ); v^cm "' 3240 (NH), 1730 
(C =0 ester), 1680 (C =0 amide), 1270 (C-0); m/e 429 (M+), 386 (M-Ac), 371 (M- 
CO2 CH3 ), 328 (M-CO 2 CH3 -AC), 313 (M-2 CO2 CH3 ), 271 (M-2 CO2 CH3 -AC).
l-{4'(S”-CMoropropyl)phe?iyl)-2-buten-l-one (36).
Anhydrous AICI3  ( 8 g, 60mmol) was was slurried in CHCI3 (25ml) and crotonyl chloride 
(24) (6.27g, 60mmol) added slowly over 5mins; a yellow colour formed as the AICI3  
dissolved. Once all the solid had dissolved, 3-chloropropylbenzene (35) (8.5g, 55mmol) 
was then added over lOmins, and was stirred for a further 30mins. The mixture was then 
quenched in ice and stirred. The organic layer was separated, washed with 5% NaHCOg, 
dried, filtered and evaporated. Column chromatography (silica; DCM 60%: 40-60°C pet. 
ether 40%) followed by cold crystallization from ether/hexane gave the title ketone (36) 
(6.5g, 53% yield); m.p. 48-50°C; (Found C, 69.84; H, 6.78. C 1 3H 1 5 CIO requires: C, 70.11; 
H, 6.79%.); v ^ c m  ' 1670 (C =0), 1620 (C=C); 0» (360MHz, CDCI3 ) 7.91-7.84+7.37-
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7.27 (4H, 1,4-disub. aryl ring), 7.08 (IH , dq, 715.13+6.35), 6.90 (IH , dq, 715.13+1.47), 
3.53 (2H, t ,7 6 .5 ) , 2.85 (2H, t ,7 7 .3 ) , 2.13-2.03 (2H, m), 2.00 (3H, dd, 76.35+1.47).
4-(4'-(3"-Chloropropyl)phenyl)-2.9-dimethyl-1.10-phenanthroline (37).
Aminoquinoline (25) (0.4g, 2.5mmol), ketone (36) (1.1 Ig, 5mmol) and KH 2 ASO4  (0.5g, 
2 .8 mmol) were disolved in c. HCl (10ml) and heated to 90°C for 36hrs. The mixture was 
then basified to pH 10 with 40% NaOH (aq.) and extracted with CHCI3 . The organic 
extracts were dried, filtered and evaporated to leave a brown oil. Column chromatography 
(silica; 2:1 DCM:40-60 pet. ether then 10% MeOH in CHCI3 ), followed by cold 
crystallization from CHClg/ether gave the crude product. The pure phenanthroline (37) 
was recrystallized from benzene (0.52g, 57% yield); m.p. 1 7 rC  dec.; (Found C, 76.36; 
H, 5.86; N, 7.63%. C2 3 H 2 1 N 2 CI requires: C, 76.55; H, 5.87; N, 7.76%.); ôy (360MHz, 
CDCI3 ) 8.10 (IH , d, 77 .81), 7.83 (IH , d, 79 .28), 7.63 (IH , d, 79.28), 7.50 (IH , d ,7  
7.81), 7.43 (IH , s), 1.5-13 (4H, 1,4-disub. aryl ring), 3.61 (2H, t, 76 .3 ), 2.97 (6 H, s)
2.91 (2H, t, 7 7 ), 2.27-2.09 (2H, s) ; m/e 360+362 (M+), 324 (M-HCl).
4-f4'-{3"-ChloropropyDphenyl)-2.9-his(trichloromethvD-l. 10-phenanthroline (38). 
From crude (37) (3.1g) using the standard perchlorination conditions. Recrystallization 
from CHClg/MeOH gave the title chlorohexachloride (38) (5.43g); m.p. 150-15TC; 
(Found C, 48.60; H, 2.64; N, 4.86%. C2 3H 15N 2 CI7  requires: C, 48.67; H, 2.66; N, 4.86%.); 
ÔH (360MHz, CDCI3 ) 8.44 (IH , d, 7  8.79), 8.33 (IH , d, 78 .79), 8.23 (IH , s), 8.08 (IH , 
d ,79.28), 7.89 (IH, d ,7  9.28), 7.54-7.42 (4H, 1,4-disub. aryl ring), 3.63 (2H, t, 76.35),
2.92 (2H, t, 77 ), 2.27-2.10 (2H, m) ; m/e 564 (M+), 529 (M-Cl), 494 (M-2C1), 459 (M- 
3C1).
4-(4'-(3"-Chloropropyl3phenyl)-2.9-bis('methoxycarbonyl)-L10-phenafithroline (39).
(38) (310mg, 0.7mmol) was stirred in 98% H 2 SO 4  (10ml) at 90°C for 3hrs. MeOH (5ml) 
was added dropwise and the mixture refluxed for 30mins. The solution was cooled and 
neutralized with solid NaHCOj, filtered and evaporated. The residues were partitioned 
between CHCl3 /water and the organic layed separated, dried, filtered and evaporated to
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leave a clear oil. Flash chromatography (silica; 4% MeOH in CHCI3), followed by 
recrystallization from CHCl3/MeOH gave the title dimethyl ester (39) (250mg, 76% yield); 
m.p. 191-193T; (Found C, 6 6 .8 6 ; H, 4.66; N, 6.21%. C^AiNzClO^ requires: C, 66.89; 
H, 4.72; N, 6.24%.); v^cm '^  1730+1720 (C=0 ), 1270 (C-0 ); Ôh (360MHz, CDCI3)
8.55-8.40 (3H, m), 8.12 (IH , d, 79 .28), 7.91 (IH , d, 79 .28), 7.55-7.40 (4H, 1,4-disub. 
aryl ring), 4.15 (6 H, s), 3.63 (2H, t, 76 .35), 2.93 (2H, t, 77 .5 ), 2.17 (2H, m) ; m/e 390 
(M-CO 2 CH3 ), 332 (M-2 CO2 CH3 ).
4~(4'-(3 "-Bromopropyl)phenyl)-2.9-bis('methoxycarhonvl)-l. 10-phenanthroline (40).
(39) (0.45g, Immol) was dissolved in MeOH (50ml) and heated. NaBr (4.12g, 40mmol) 
was added and the mixture refluxed for 7 days. The solution was evaporated and the 
residues partitioned between CHCI3/H 2 O. The organic solution was then dried, filtered and 
evaporated to give a pale coloured solid. The cmde compound was then recrystallized 
from CHClj/MeOH to give the title dimethyl ester (40) (0.42g). Analysis o f the compound 
by FAB confirmed that a small amount o f  chloride was still present; Ôh (90MHz, CDCI3)
8.55-8,40 (3H, m), 8.12 (IH , d, 79 .28), 7.91 (IH , d, 79 .28), 7.55-7.40 (4H, 1,4-disub. 
aryl ring), 4.15 (6 H, s), 3.48 (2H, t, 7  6.35), 2.93 (2H, t, 7  7.5), 2.17 (2H, m) ; m/e 
493+495 (M+H),515+517 (M+H).
4-('4'-('3”-('N-Phenanthridinium)propyl)phenyl)-2.9-bisfmethoxycarbonvl)-1.10 - 
phenanthroline (41).
(40) (lOOmg, 0.2mmol) and phenanthridine (1 lOmg, 0.6mmol) were mixed and heated to 
120"C under argon for 3hrs. The mixture was then dissolved in chloroform (2ml) and then 
dripped through a scintered funnel into stirring, cold diethyl ether (30ml). The product 
precipitated out and the process was repeated to give a crude sample o f the title 
phenanthridinium salt (40). Purification and analysis of this compound proved difficult 
and the salt was hydrolysed directly.
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Experimental
4-(4'-(3”-(N-Phenanthridmium)propvl)phenyl)-L10-phenanthroîine-2.9-dicarboxvlic 
acid (34).
Crude (41) (340mg) was dissolved in water (7ml), formic acid (5ml) and 49% HBr (1 
drop). This mixture was heated at reflux for 16hrs, then boiled to a low volume. Upon 
cooling a solid separated out. The solid was collected, washed with water to give the title 
probe (34) (2 2 0 mg, 67%); m.p. 213°C dec.; (Found positive ion of product, 564.1945. 
CggH^gNgO^Br requires 564.1923.); m/e (FAB) 564 (M+), 520 (M-CO^), 476 (M-2 CO2 ).
152
R56X001.SP
2.28
2.2
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680 700 720660600560 580 620 640
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Results o f 1.4 X lO'^M R and Q targets with probe P using sensitizer/intercalator (2).
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Q H V B R 0 0 1 .S P
130 —
120  —
1 1 0  —
100
90 —
70 —
60 —
SO —
40 —
SO —
20  —
0.1
560 600 620580 640 660 700 720 740
550.0 750.0
Results o f 8  X lO'^M R and Q targets w ith probe P using sensitizer/intercalator (2).
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4.87
4.5
3.5
3.0
2.S
2.0
0.5
y /
0.00
560 580 SOD 520 700 720 740
Test using the Cystic Fibrosis TR gene, exon 11 using PGR amplified targets at 1x10" M; 
probe (3284) and sensitizer/intercalator (34) at 1x10*^.
a) GD/GD, b) GD/normal, c) normal/normal, d) control (exonlO). Signals from tests in 
the absence o f targets not visible.
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HPLC trace of unconjugated Mutant probe 3849. Solvent 8.75% MeCN in water using 
Spherisorb O DS l, 5 micron.
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HPLC trace of conjugated mutant probe 3849 (EDTA/Eu^ ) Condiditons same as 
previous run overleaf.
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HPLC trace of unconjugated normal probe 3848. 17% MeCN with 0.1 TEAA 
(triethylammonium acetate).
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